{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:46:47Z","timestamp":1793710007727,"version":"4.6.1"},"reference-count":413,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"ProjektDeal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02881-4","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:01:38Z","timestamp":1787097698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Role of epithelial-mesenchymal transition (EMT) in malignancies: current status and future prospects"],"prefix":"10.1038","volume":"11","author":[{"given":"Vafa","family":"Meftahpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tikam Chand","family":"Dakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarek","family":"Maciaczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo G. H.","family":"Schmidt-Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"2881_CR1","doi-asserted-by":"publisher","first-page":"14481","DOI":"10.3390\/ijms241914481","volume":"24","author":"J Sarrand","year":"2023","unstructured":"Sarrand, J. & Soyfoo, M. S. Involvement of epithelial-mesenchymal transition (EMT) in autoimmune diseases. Int. J. Mol. Sci. 24, 14481 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2881_CR2","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3390\/cells10071587","volume":"10","author":"GD Marconi","year":"2021","unstructured":"Marconi, G. D. et al. Epithelial-mesenchymal transition (EMT): the type-2 EMT in wound healing, tissue regeneration and organ fibrosis. Cells 10, 1587 (2021).","journal-title":"Cells"},{"key":"2881_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203614","volume":"10","author":"P Srivastava","year":"2023","unstructured":"Srivastava, P. et al. Defined microenvironments trigger in vitro gastrulation in human pluripotent stem cells. Adv. Sci. 10, 2203614 (2023).","journal-title":"Adv. Sci."},{"key":"2881_CR4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3109\/03008207.2015.1060970","volume":"56","author":"J Banyard","year":"2015","unstructured":"Banyard, J. & Bielenberg, D. R. The role of EMT and MET in cancer dissemination. Connect. Tissue Res. 56, 403\u2013413 (2015).","journal-title":"Connect. Tissue Res."},{"key":"2881_CR5","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420\u20131428 (2009).","journal-title":"J. Clin. Invest."},{"key":"2881_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/biology12020239","volume":"12","author":"AI Lorenzo-Pouso","year":"2023","unstructured":"Lorenzo-Pouso, A. I. et al. Overexpression of E-Cadherin Is a favorable prognostic biomarker in oral squamous cell carcinoma: a systematic review and meta-analysis. Biology 12, 239 (2023).","journal-title":"Biology"},{"key":"2881_CR7","first-page":"61","volume":"8","author":"AJ Knights","year":"2012","unstructured":"Knights, A. J., Funnell, A. P., Crossley, M. & Pearson, R. C. Holding tight: cell junctions and cancer spread. Trends Cancer Res. 8, 61\u201369 (2012).","journal-title":"Trends Cancer Res."},{"key":"2881_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00018-023-04907-4","volume":"80","author":"Y Ren","year":"2023","unstructured":"Ren, Y. et al. Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance. Cell. Mol. Life Sci. 80, 263 (2023).","journal-title":"Cell. Mol. Life Sci."},{"key":"2881_CR9","first-page":"250","volume":"21","author":"V Meftahpour","year":"2022","unstructured":"Meftahpour, V. et al. Prognostic significance and therapeutic potentials of immune checkpoints in osteosarcoma. EXCLI J. 21, 250 (2022).","journal-title":"EXCLI J."},{"key":"2881_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre, A. & Weinberg, R. A. New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 20, 69\u201384 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2881_CR11","doi-asserted-by":"crossref","unstructured":"Heinz, M. C. et al. Liver colonization by colorectal cancer metastases requires YAP-controlled plasticity at the micrometastatic stage. 82, 1953\u20131968, (2022).","DOI":"10.1158\/0008-5472.CAN-21-0933"},{"key":"2881_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ncb3513","volume":"19","author":"AM Krebs","year":"2017","unstructured":"Krebs, A. M. et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat. Cell Biol. 19, 518\u2013529 (2017).","journal-title":"Nat. Cell Biol."},{"key":"2881_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrc.2017.118","volume":"18","author":"T Brabletz","year":"2018","unstructured":"Brabletz, T., Kalluri, R., Nieto, M. A. & Weinberg, R. A. EMT in cancer. Nat. Rev. Cancer 18, 128\u2013134 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"2881_CR14","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/nm.3336","volume":"19","author":"WL Tam","year":"2013","unstructured":"Tam, W. L. & Weinberg, R. A. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat. Med. 19, 1438\u20131449 (2013).","journal-title":"Nat. Med."},{"key":"2881_CR15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.4049\/jimmunol.1600458","volume":"197","author":"PJ Chockley","year":"2016","unstructured":"Chockley, P. J. & Keshamouni, V. G. Immunological consequences of epithelial-mesenchymal transition in tumor progression. J. Immunol. 197, 691\u2013698 (2016).","journal-title":"J. Immunol."},{"key":"2881_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang, J. et al. Guidelines and definitions for research on epithelial\u2013mesenchymal transition. Nat. Rev. Mol. Cell Biol. 21, 341\u2013352 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2881_CR17","doi-asserted-by":"publisher","first-page":"100773","DOI":"10.1016\/j.tranon.2020.100773","volume":"13","author":"D Ribatti","year":"2020","unstructured":"Ribatti, D., Tamma, R. & Annese, T. Epithelial-mesenchymal transition in cancer: a historical overview. Transl. Oncol. 13, 100773 (2020).","journal-title":"Transl. Oncol."},{"key":"2881_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cpt.2024.07.002","volume":"3","author":"R Bangarh","year":"2025","unstructured":"Bangarh, R. et al. Dynamics of epithelial\u2013mesenchymal plasticity driving cancer drug resistance. Cancer Pathogenes. Ther. 3, 120\u2013128 (2025).","journal-title":"Cancer Pathogenes. Ther."},{"key":"2881_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.devcel.2019.04.010","volume":"49","author":"W Lu","year":"2019","unstructured":"Lu, W. & Kang, Y. Epithelial-mesenchymal plasticity in cancer progression and metastasis. Dev. Cell 49, 361\u2013374 (2019).","journal-title":"Dev. Cell"},{"key":"2881_CR20","doi-asserted-by":"crossref","unstructured":"Tomecka, P. et al. Factors determining epithelial-mesenchymal transition in cancer progression. Int. J. Mol. Sci. 25, 8972 (2024).","DOI":"10.3390\/ijms25168972"},{"key":"2881_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang, Y., Hong, W. & Wei, X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J. Hematol. Oncol. 15, 129 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"2881_CR22","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1158\/1078-0432.CCR-15-1434","volume":"22","author":"Y Lou","year":"2016","unstructured":"Lou, Y. et al. Epithelial\u2013mesenchymal transition is associated with a distinct tumor microenvironment including elevation of inflammatory signals and multiple immune checkpoints in lung adenocarcinoma. Clin. Cancer Res. 22, 3630\u20133642 (2016).","journal-title":"Clin. Cancer Res."},{"key":"2881_CR23","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.celrep.2019.04.048","volume":"27","author":"CC Guo","year":"2019","unstructured":"Guo, C. C. et al. Dysregulation of EMT drives the progression to clinically aggressive sarcomatoid bladder cancer. Cell Rep. 27, 1781\u20131793 (2019).","journal-title":"Cell Rep."},{"key":"2881_CR24","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1158\/0008-5472.CAN-16-3292","volume":"77","author":"A Dongre","year":"2017","unstructured":"Dongre, A. et al. Epithelial-to-mesenchymal transition contributes to immunosuppression in breast carcinomas. Cancer Res. 77, 3982\u20133989 (2017).","journal-title":"Cancer Res."},{"key":"2881_CR25","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.ajpath.2015.12.029","volume":"186","author":"R Murakami","year":"2016","unstructured":"Murakami, R. et al. Establishment of a novel histopathological classification of high-grade serous ovarian carcinoma correlated with prognostically distinct gene expression subtypes. Am. J. Pathol. 186, 1103\u20131113 (2016).","journal-title":"Am. J. Pathol."},{"key":"2881_CR26","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1158\/2159-8290.CD-20-0603","volume":"11","author":"A Dongre","year":"2021","unstructured":"Dongre, A. et al. Direct and indirect regulators of epithelial\u2013mesenchymal transition\u2013mediated immunosuppression in breast carcinomas. Cancer Discov. 11, 1286\u20131305 (2021).","journal-title":"Cancer Discov."},{"key":"2881_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.cpt.2022.12.002","volume":"1","author":"H Ahmed","year":"2023","unstructured":"Ahmed, H. et al. Role of T cells in cancer immunotherapy: opportunities and challenges. Cancer Pathog. Ther. 1, 116\u2013126 (2023).","journal-title":"Cancer Pathog. Ther."},{"key":"2881_CR28","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.3390\/cancers16091626","volume":"16","author":"TC Dakal","year":"2024","unstructured":"Dakal, T. C. et al. Predictive and prognostic relevance of tumor-infiltrating immune cells: tailoring personalized treatments against different. Cancer Types 16, 1626 (2024).","journal-title":"Cancer Types"},{"key":"2881_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155567","volume":"262","author":"TC Dakal","year":"2024","unstructured":"Dakal, T. C. et al. Emerging methods and techniques for cancer biomarker discovery. Pathol. - Res. Pract. 262, 155567 (2024).","journal-title":"Pathol. - Res. Pract."},{"key":"2881_CR30","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s11011-024-01414-8","volume":"39","author":"TC Dakal","year":"2024","unstructured":"Dakal, T. C., Kakde, G. S. & Maurya, P. K. Genomic, epigenomic and transcriptomic landscape of glioblastoma. Metab. Brain Dis. 39, 1591\u20131611 (2024).","journal-title":"Metab. Brain Dis."},{"key":"2881_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.156280","volume":"276","author":"A Beura","year":"2025","unstructured":"Beura, A. et al. Next generation DNA sequencing data analysis and its application in clinical genomics. Pathol. - Res. Pract. 276, 156280 (2025).","journal-title":"Pathol. - Res. Pract."},{"key":"2881_CR32","doi-asserted-by":"publisher","first-page":"128384","DOI":"10.1016\/j.micres.2025.128384","volume":"303","author":"A Kumar","year":"2026","unstructured":"Kumar, A., Xu, C. & Dakal, T. C. Microbiome based precision medicine through integrated multiomics and machine learning. Microbiol. Res. 303, 128384 (2026).","journal-title":"Microbiol. Res."},{"key":"2881_CR33","doi-asserted-by":"publisher","first-page":"155728","DOI":"10.1016\/j.prp.2024.155728","volume":"266","author":"TC Dakal","year":"2025","unstructured":"Dakal, T. C. et al. Genetic and epigenetic regulation of non-coding RNAs: Implications in cancer metastasis, stemness and drug resistance. Pathol. - Res. Pract. 266, 155728 (2025).","journal-title":"Pathol. - Res. Pract."},{"key":"2881_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.582","volume":"5","author":"TC Dakal","year":"2024","unstructured":"Dakal, T. C. et al. Oncogenes and tumor suppressor genes: functions and roles in cancers. MedComm (2020) 5, e582 (2024).","journal-title":"MedComm (2020)"},{"key":"2881_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.insi.2025.100159","volume":"2","author":"TC Dakal","year":"2026","unstructured":"Dakal, T. C. et al. Integrated computational biology revealed ellagic acid exerts antioxidant and anticancer activities through inhibition of ROS-induced JNK\/p38 MAPK kinase pathway. Silico Res. Biomed. 2, 100159 (2026).","journal-title":"Silico Res. Biomed."},{"key":"2881_CR36","doi-asserted-by":"publisher","first-page":"17259","DOI":"10.1074\/jbc.M700075200","volume":"282","author":"SK Dissanayake","year":"2007","unstructured":"Dissanayake, S. K. et al. The Wnt5A\/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J. Biol. Chem. 282, 17259\u201317271 (2007).","journal-title":"J. Biol. Chem."},{"key":"2881_CR37","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/labinvest.2013.69","volume":"93","author":"C-Y Liu","year":"2013","unstructured":"Liu, C.-Y. et al. M2-polarized tumor-associated macrophages promoted epithelial\u2013mesenchymal transition in pancreatic cancer cells, partially through TLR4\/IL-10 signaling pathway. Lab. Investig. 93, 844\u2013854 (2013).","journal-title":"Lab. Investig."},{"key":"2881_CR38","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3390\/biom11060782","volume":"11","author":"C Lachat","year":"2021","unstructured":"Lachat, C., Peixoto, P. & Hervouet, E. Epithelial to mesenchymal transition history: from embryonic development to cancers. Biomolecules 11, 782 (2021).","journal-title":"Biomolecules"},{"key":"2881_CR39","doi-asserted-by":"crossref","unstructured":"Dakal, T. C., Sharma, N. K. & Sharma, A. Editorial: Revisiting the challenges and opportunities in cancer drug resistance. Front. Mol. Biosci. 11\u20132024 (2024).","DOI":"10.3389\/fmolb.2024.1497754"},{"key":"2881_CR40","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1172\/JCI38019","volume":"119","author":"H Acloque","year":"2009","unstructured":"Acloque, H. et al. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J. Clin. Investig. 119, 1438\u20131449 (2009).","journal-title":"J. Clin. Investig."},{"key":"2881_CR41","doi-asserted-by":"publisher","first-page":"e108647","DOI":"10.15252\/embj.2021108647","volume":"40","author":"S Brabletz","year":"2021","unstructured":"Brabletz, S., Schuhwerk, H., Brabletz, T. & Stemmler, M. P. Dynamic EMT: a multi-tool for tumor progression. EMBO J. 40, e108647 (2021).","journal-title":"EMBO J."},{"key":"2881_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02338-2","volume":"24","author":"H Allgayer","year":"2025","unstructured":"Allgayer, H. et al. Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: the status quo of methods and experimental models 2025. Mol. Cancer 24, 167 (2025).","journal-title":"Mol. Cancer"},{"key":"2881_CR43","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue, T. & Weinberg, R. A. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat. Rev. Clin. Oncol. 14, 611\u2013629 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2881_CR44","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/1878-0261.12093","volume":"11","author":"S Terry","year":"2017","unstructured":"Terry, S. et al. New insights into the role of EMT in tumor immune escape. Mol. Oncol. 11, 824\u2013846 (2017).","journal-title":"Mol. Oncol."},{"key":"2881_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2021.166240","volume":"1867","author":"A Sharma","year":"2021","unstructured":"Sharma, A. et al. Long non-coding RNAs orchestrate various molecular and cellular processes by modulating epithelial-mesenchymal transition in head and neck squamous cell carcinoma. Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 1867, 166240 (2021).","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"2881_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.495","volume":"5","author":"M Gu","year":"2024","unstructured":"Gu, M. et al. Epigenetic regulation in cancer. MedComm 5, e495 (2024).","journal-title":"MedComm"},{"key":"2881_CR47","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1128\/MCB.00019-16","volume":"36","author":"Y Yang","year":"2016","unstructured":"Yang, Y. et al. Determination of a comprehensive alternative splicing regulatory network and combinatorial regulation by key factors during the epithelial-to-mesenchymal transition. Mol. Cell Biol. 36, 1704\u20131719 (2016).","journal-title":"Mol. Cell Biol."},{"key":"2881_CR48","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/ncb1173","volume":"6","author":"BP Zhou","year":"2004","unstructured":"Zhou, B. P. et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 6, 931\u2013940 (2004).","journal-title":"Nat. Cell Biol."},{"key":"2881_CR49","doi-asserted-by":"crossref","unstructured":"Zhang, J., Tian, X. J. & Xing, J. Signal transduction pathways of EMT Induced by TGF-\u03b2, SHH, and WNT and their crosstalks. J. Clin. Med. 5, 41 (2016).","DOI":"10.3390\/jcm5040041"},{"key":"2881_CR50","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/cr.2009.5","volume":"19","author":"J Xu","year":"2009","unstructured":"Xu, J., Lamouille, S. & Derynck, R. TGF-\u03b2-induced epithelial to mesenchymal transition. Cell Res. 19, 156\u2013172 (2009).","journal-title":"Cell Res."},{"key":"2881_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.659","volume":"5","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Epithelial\u2013mesenchymal plasticity in cancer: signaling pathways and therapeutic targets. MedComm 5, e659 (2024).","journal-title":"MedComm"},{"key":"2881_CR52","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao, H. et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct. Target Ther. 6, 263 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"2881_CR53","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1042\/CS20201474","volume":"136","author":"R Cunningham","year":"2022","unstructured":"Cunningham, R. & Hansen, C. G. The Hippo pathway in cancer: YAP\/TAZ and TEAD as therapeutic targets in cancer. Clin. Sci. (Lond., Engl. : 1979) 136, 197\u2013222 (2022).","journal-title":"Clin. Sci. (Lond., Engl. : 1979)"},{"key":"2881_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.446","volume":"4","author":"N Zhang","year":"2023","unstructured":"Zhang, N. & Li, Y. Receptor tyrosine kinases: biological functions and anticancer targeted therapy. MedComm 4, e446 (2023).","journal-title":"MedComm"},{"key":"2881_CR55","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-024-01899-w","volume":"9","author":"C Tomuleasa","year":"2024","unstructured":"Tomuleasa, C. et al. Therapeutic advances of targeting receptor tyrosine kinases in cancer. Signal Transduct. Target. Ther. 9, 201 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2881_CR56","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10142-024-01394-z","volume":"24","author":"NK Sharma","year":"2024","unstructured":"Sharma, N. K. et al. Engineering circular RNA for molecular and metabolic reprogramming. Funct. Integr. Genomics 24, 117 (2024).","journal-title":"Funct. Integr. Genomics"},{"key":"2881_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pbiomolbio.2025.05.003","volume":"197","author":"Y Zeng","year":"2025","unstructured":"Zeng, Y. et al. Advances in the mechanisms of HIF-1\u03b1-enhanced tumor glycolysis and its relation to dedifferentiation. Prog. Biophys. Mol. Biol. 197, 1\u201310 (2025).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"2881_CR58","doi-asserted-by":"publisher","first-page":"1431418","DOI":"10.3389\/fonc.2024.1431418","volume":"14","author":"M Haque","year":"2024","unstructured":"Haque, M., Shyanti, R. K. & Mishra, M. K. Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer. Front Oncol. 14, 1431418 (2024).","journal-title":"Front Oncol."},{"key":"2881_CR59","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s00204-021-03063-7","volume":"95","author":"J De Las Rivas","year":"2021","unstructured":"De Las Rivas, J. et al. Cancer drug resistance induced by EMT: novel therapeutic strategies. Arch. Toxicol. 95, 2279\u20132297 (2021).","journal-title":"Arch. Toxicol."},{"key":"2881_CR60","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3389\/fonc.2019.01044","volume":"9","author":"X Zhu","year":"2019","unstructured":"Zhu, X., Chen, L., Liu, L. & Niu, X. EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies. Front. Oncol. 9, 1044 (2019).","journal-title":"Front. Oncol."},{"key":"2881_CR61","doi-asserted-by":"crossref","unstructured":"Hao, Y., Baker, D. & Ten Dijke, P. TGF-\u03b2-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis. Int. J. Mol. Sci. 20, (2019).","DOI":"10.3390\/ijms20112767"},{"key":"2881_CR62","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.2174\/138161211797249260","volume":"17","author":"JM Heddleston","year":"2011","unstructured":"Heddleston, J. M. et al. Glioma stem cell maintenance: the role of the microenvironment. Curr. Pharm. Des. 17, 2386\u20132401 (2011).","journal-title":"Curr. Pharm. Des."},{"key":"2881_CR63","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1586\/14737175.2014.964211","volume":"14","author":"GK Gray","year":"2014","unstructured":"Gray, G. K., McFarland, B. C., Nozell, S. E. & Benveniste, E. N. NF-\u03baB and STAT3 in glioblastoma: therapeutic targets coming of age. Expert Rev. Neurother. 14, 1293\u20131306 (2014).","journal-title":"Expert Rev. Neurother."},{"key":"2881_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-021-00761-8","volume":"19","author":"JD Amack","year":"2021","unstructured":"Amack, J. D. Cellular dynamics of EMT: lessons from live in vivo imaging of embryonic development. Cell Commun. Signal. 19, 79 (2021).","journal-title":"Cell Commun. Signal."},{"key":"2881_CR65","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto, M. A., Huang, R. Y.-J., Jackson, R. A. & Thiery, J. P. EMT: 2016. Cell 166, 21\u201345 (2016).","journal-title":"Cell"},{"key":"2881_CR66","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri, R. et al. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420\u20131428 (2009).","journal-title":"J. Clin. Invest."},{"key":"2881_CR67","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1039\/D2BM01625G","volume":"11","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. A multifunctional black phosphorus-based adhesive patch intrinsically induces partial EMT for effective burn wound healing. Biomater. Sci. 11, 235\u2013247 (2023).","journal-title":"Biomater. Sci."},{"key":"2881_CR68","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3389\/fonc.2020.00587","volume":"10","author":"V Fedele","year":"2020","unstructured":"Fedele, V. & Melisi, D. Permissive state of EMT: the role of immune cell compartment. Front. Oncol. 10, 587 (2020).","journal-title":"Front. Oncol."},{"key":"2881_CR69","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1177\/1933719118776790","volume":"26","author":"L Feng","year":"2019","unstructured":"Feng, L., Allen, T. K., Marinello, W. P. & Murtha, A. P. Roles of progesterone receptor membrane component 1 in oxidative stress\u2013induced aging in chorion cells. Reprod. Sci. 26, 394\u2013403 (2019).","journal-title":"Reprod. Sci."},{"key":"2881_CR70","doi-asserted-by":"crossref","unstructured":"Richardson, L. S., Taylor, R. N. & Menon, R. Reversible EMT and MET mediate amnion remodeling during pregnancy and labor. Sci. Signal. 13, eaay1486 (2020).","DOI":"10.1126\/scisignal.aay1486"},{"key":"2881_CR71","doi-asserted-by":"publisher","first-page":"1848212","DOI":"10.1080\/21688370.2020.1848212","volume":"9","author":"MS Adil","year":"2021","unstructured":"Adil, M. S., Narayanan, S. P. & Somanath, P. R. Cell-cell junctions: structure and regulation in physiology and pathology. Tissue Barriers 9, 1848212 (2021).","journal-title":"Tissue Barriers"},{"key":"2881_CR72","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3390\/ijms21041349","volume":"21","author":"S Shi","year":"2020","unstructured":"Shi, S. et al. EMT transcription factors are involved in the altered cell adhesion under simulated microgravity effect or overloading by regulation of E-cadherin. Int. J. Mol. Sci. 21, 1349 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"2881_CR73","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jtos.2023.06.008","volume":"29","author":"S Singh","year":"2023","unstructured":"Singh, S. et al. Epithelial-mesenchymal transition in the lacrimal gland morphogenesis, damage and repair. Ocul. Surf. 29, 401\u2013405 (2023).","journal-title":"Ocul. Surf."},{"key":"2881_CR74","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/wrr.12920","volume":"29","author":"Z Ostrowska-Podhorodecka","year":"2021","unstructured":"Ostrowska-Podhorodecka, Z. & McCulloch, C. A. Vimentin regulates the assembly and function of matrix adhesions. Wound Repair Regen. 29, 602\u2013612 (2021).","journal-title":"Wound Repair Regen."},{"key":"2881_CR75","first-page":"81","volume":"8","author":"N Yarom","year":"2013","unstructured":"Yarom, N. et al. Phase I clinical trial of Exherin (ADH-1) in patients with advanced solid tumors. Curr. Clin. Pharmacol. 8, 81\u201388 (2013).","journal-title":"Curr. Clin. Pharmacol."},{"key":"2881_CR76","doi-asserted-by":"crossref","unstructured":"Huang, Z. et al. Epithelial\u2013mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities. MedComm. 3, e144 (2022).","DOI":"10.1002\/mco2.144"},{"key":"2881_CR77","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cpt.2024.07.001","volume":"3","author":"MCP Dela Cruz","year":"2025","unstructured":"Dela Cruz, M. C. P. & Medina, P. M. B. Epithelial\u2013mesenchymal transition (EMT) and its role in acquired epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) chemoresistance in non-small cell lung cancer (NSCLC). Cancer Pathogenes. Ther. 3, 215\u2013225 (2025).","journal-title":"Cancer Pathogenes. Ther."},{"key":"2881_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2024.120293","volume":"264","author":"K Yi","year":"2025","unstructured":"Yi, K. et al. Bisphenol S exposure promotes stemness of triple-negative breast cancer cells via regulating Gli1-mediated Sonic hedgehog pathway. Environ. Res. 264, 120293 (2025).","journal-title":"Environ. Res."},{"key":"2881_CR79","doi-asserted-by":"crossref","unstructured":"Visal, T. H. et al. Accumulation of CD38 in hybrid epithelial\/mesenchymal cells promotes immune remodeling and metastasis in breast cancer. 85, 894-911, (2025).","DOI":"10.1158\/0008-5472.CAN-24-0400"},{"key":"2881_CR80","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007895","volume":"12","author":"M Parodi","year":"2024","unstructured":"Parodi, M. et al. Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cells. J. Immunother. cancer 12, e007895 (2024).","journal-title":"J. Immunother. cancer"},{"key":"2881_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.113023","volume":"28","author":"G Dimari","year":"2025","unstructured":"Dimari, G. et al. Mesenchymal-epithelial transition reduces proliferation but increases immune evasion in tumor spheroids. iScience 28, 113023 (2025).","journal-title":"iScience"},{"key":"2881_CR82","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41392-022-00944-w","volume":"7","author":"C Fan","year":"2022","unstructured":"Fan, C. et al. OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-\u03b2 type I receptor. Signal Transduct. Target. Ther. 7, 126 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2881_CR83","doi-asserted-by":"publisher","first-page":"154836","DOI":"10.1016\/j.prp.2023.154836","volume":"251","author":"HT Morris","year":"2023","unstructured":"Morris, H. T., Bamlet, W. R., Razidlo, G. L. & Machesky, L. M. FSCN1 and epithelial mesenchymal transformation transcription factor expression in human pancreatic intraepithelial neoplasia and ductal adenocarcinoma. Pathol.-Res. Pract. 251, 154836 (2023).","journal-title":"Pathol.-Res. Pract."},{"key":"2881_CR84","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41419-023-05974-y","volume":"14","author":"Y He","year":"2023","unstructured":"He, Y. et al. ZHX2 deficiency enriches hybrid MET cells through regulating E-cadherin expression. Cell Death Dis. 14, 444 (2023).","journal-title":"Cell Death Dis."},{"key":"2881_CR85","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.3390\/ijms26083617","volume":"26","author":"MC Rapanotti","year":"2025","unstructured":"Rapanotti, M. C. et al. The clinical relevance of epithelial-to-mesenchymal transition hallmarks: a cut-off-based approach in healthy and cancerous cell lines. Int. J. Mol. Sci. 26, 3617 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"2881_CR86","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11538-024-01277-1","volume":"86","author":"M Rashid","year":"2024","unstructured":"Rashid, M., Devi, B. M. & Banerjee, M. Combinatorial cooperativity in miR200-Zeb feedback network can control epithelial\u2013mesenchymal transition. Bull. Math. Biol. 86, 48 (2024).","journal-title":"Bull. Math. Biol."},{"key":"2881_CR87","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41419-020-2340-4","volume":"11","author":"P Lindner","year":"2020","unstructured":"Lindner, P. et al. EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells. Cell Death Dis. 11, 147 (2020).","journal-title":"Cell Death Dis."},{"key":"2881_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12832-z","volume":"10","author":"R Manshouri","year":"2019","unstructured":"Manshouri, R. et al. ZEB1\/NuRD complex suppresses TBC1D2b to stimulate E-cadherin internalization and promote metastasis in lung cancer. Nat. Commun. 10, 5125 (2019).","journal-title":"Nat. Commun."},{"key":"2881_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-024-01888-5","volume":"26","author":"H-C Lien","year":"2024","unstructured":"Lien, H.-C. et al. Characteristics and transcriptional regulators of spontaneous epithelial\u2013mesenchymal transition in genetically unperturbed patient-derived non-spindled breast carcinoma. Breast Cancer Res. 26, 130 (2024).","journal-title":"Breast Cancer Res."},{"key":"2881_CR90","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1146\/annurev-pathmechdis-051222-122423","volume":"19","author":"R Fontana","year":"2024","unstructured":"Fontana, R., Mestre-Farrera, A. & Yang, J. Update on Epithelial-Mesenchymal Plasticity in Cancer Progression. Annu. Rev. Pathol. 19, 133\u2013156 (2024).","journal-title":"Annu. Rev. Pathol."},{"key":"2881_CR91","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11060-020-03448-1","volume":"151","author":"R Medikonda","year":"2021","unstructured":"Medikonda, R. et al. A review of glioblastoma immunotherapy. J. Neuro-Oncol. 151, 41\u201353 (2021).","journal-title":"J. Neuro-Oncol."},{"key":"2881_CR92","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3390\/ijms23031311","volume":"23","author":"Y Li","year":"2022","unstructured":"Li, Y., Sharma, A., Maciaczyk, J. & Schmidt-Wolf, I. G. H. Recent development in NKT-based immunotherapy of glioblastoma: From bench to bedside. Int. J. Mol. Sci. 23, 1311 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2881_CR93","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1089\/jir.2023.0180","volume":"44","author":"S Zhong","year":"2024","unstructured":"Zhong, S., Zhang, Y., Lu, X. & Meftahpour, V. The therapeutic potential of cytokine-induced killer in patients with cancer. J. Interferon Cytokine Res. 44, 99\u2013110 (2024).","journal-title":"J. Interferon Cytokine Res."},{"key":"2881_CR94","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/emmm.201302827","volume":"5","author":"FA Siebzehnrubl","year":"2013","unstructured":"Siebzehnrubl, F. A. et al. The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol. Med. 5, 1196\u20131212 (2013).","journal-title":"EMBO Mol. Med."},{"key":"2881_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2022.147782","volume":"1778","author":"Y Sun","year":"2022","unstructured":"Sun, Y. et al. The epithelial-mesenchymal transition of glioma cells promotes tissue factor expression via the miR200a\/ZEB1 axis. Brain Res. 1778, 147782 (2022).","journal-title":"Brain Res."},{"key":"2881_CR96","doi-asserted-by":"crossref","unstructured":"Hanna, G. K. et al. ZEB1 loss increases glioma stem cell tumorigenicity and resistance to chemoradiation. 138, 1313\u20131324, (2022).","DOI":"10.3171\/2022.7.JNS22259"},{"key":"2881_CR97","doi-asserted-by":"crossref","unstructured":"Setlai, B. P. et al. MicroRNA interrelated epithelial mesenchymal transition (EMT) in glioblastoma. 13, 244, (2022).","DOI":"10.3390\/genes13020244"},{"key":"2881_CR98","doi-asserted-by":"crossref","unstructured":"Durand, S. et al. ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions. 43, 1489\u20131505, (2024).","DOI":"10.1038\/s41388-024-03010-7"},{"key":"2881_CR99","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jcmgh.2023.07.002","volume":"16","author":"F-F Chan","year":"2023","unstructured":"Chan, F.-F. & Wong, C.-M. ZEB1 fuels serine metabolism to promote HCC metastasis. Cell. Mol. Gastroenterol. Hepatol. 16, 646 (2023).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"2881_CR100","doi-asserted-by":"publisher","first-page":"969032","DOI":"10.3389\/fonc.2022.969032","volume":"12","author":"Y Sun","year":"2022","unstructured":"Sun, Y., He, P., Li, L. & Ding, X. The significance of the crosstalk between ubiquitination or deubiquitination and ncRNAs in non-small cell lung cancer. Front Oncol. 12, 969032 (2022).","journal-title":"Front Oncol."},{"key":"2881_CR101","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jcmgh.2023.06.006","volume":"16","author":"H Wang","year":"2023","unstructured":"Wang, H. et al. ZEB1 transcriptionally activates PHGDH to facilitate carcinogenesis and progression of HCC. Cell. Mol. Gastroenterol. Hepatol. 16, 541\u2013556 (2023).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"2881_CR102","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/s41418-025-01463-1","volume":"32","author":"Z Tan","year":"2025","unstructured":"Tan, Z. et al. Tripartite motif-containing protein 26 promotes colorectal cancer growth by inactivating p53. Cell Death Differ. 32, 1142\u20131152 (2025).","journal-title":"Cell Death Differ."},{"key":"2881_CR103","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.164629","volume":"8","author":"E S\u00e1nchez-Till\u00f3","year":"2023","unstructured":"S\u00e1nchez-Till\u00f3, E. et al. The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas. Jci Insight 8, e164629 (2023).","journal-title":"Jci Insight"},{"key":"2881_CR104","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3390\/biomedicines12081915","volume":"12","author":"D Cuevas","year":"2024","unstructured":"Cuevas, D. et al. The role of epithelial-to-mesenchymal transition transcription factors (EMT-TFs) in acute myeloid leukemia progression. Biomedicines 12, 1915 (2024).","journal-title":"Biomedicines"},{"key":"2881_CR105","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13046-023-02757-3","volume":"42","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. ZEB1-mediated biogenesis of circNIPBL sustains the metastasis of bladder cancer via Wnt\/\u03b2-catenin pathway. J. Exp. Clin. Cancer Res. 42, 191 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2881_CR106","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13046-023-02757-3","volume":"42","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. ZEB1-mediated biogenesis of circNIPBL sustains the metastasis of bladder cancer via Wnt\/\u03b2-catenin pathway. J. Exp. Clin. Cancer Res 42, 191 (2023).","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"2881_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01804-z","volume":"22","author":"M Jiang","year":"2023","unstructured":"Jiang, M. et al. Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1. Mol. cancer 22, 113 (2023).","journal-title":"Mol. cancer"},{"key":"2881_CR108","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1387\/ijdb.082747rb","volume":"53","author":"RM Barnes","year":"2009","unstructured":"Barnes, R. M. & Firulli, A. B. A twist of insight - the role of Twist-family bHLH factors in development. Int. J. Dev. Biol. 53, 909\u2013924 (2009).","journal-title":"Int. J. Dev. Biol."},{"key":"2881_CR109","unstructured":"Saitoh, M. 21-29 (Elsevier)."},{"key":"2881_CR110","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","volume":"117","author":"J Yang","year":"2004","unstructured":"Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. cell 117, 927\u2013939 (2004).","journal-title":"cell"},{"key":"2881_CR111","doi-asserted-by":"publisher","first-page":"R719","DOI":"10.1016\/j.cub.2004.08.048","volume":"14","author":"AE Vernon","year":"2004","unstructured":"Vernon, A. E. & LaBonne, C. Tumor metastasis: a new twist on epithelial\u2013mesenchymal transitions. Curr. Biol. 14, R719\u2013R721 (2004).","journal-title":"Curr. Biol."},{"key":"2881_CR112","doi-asserted-by":"crossref","unstructured":"Norozi, F. et al. Twist as a new prognostic marker in hematological malignancies. 18, 113\u2013124, (2016).","DOI":"10.1007\/s12094-015-1357-0"},{"key":"2881_CR113","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/nan.12714","volume":"47","author":"NM Wirsik","year":"2021","unstructured":"Wirsik, N. M. et al. TGF-\u03b2 activates pericytes via induction of the epithelial-to-mesenchymal transition protein SLUG in glioblastoma. Neuropathol. Appl. Neurobiol. 47, 768\u2013780 (2021).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"2881_CR114","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s10571-019-00677-5","volume":"39","author":"S-J Oh","year":"2019","unstructured":"Oh, S.-J. et al. The role played by SLUG, an epithelial\u2013mesenchymal transition factor, in invasion and therapeutic resistance of malignant glioma. Cell. Mol. Neurobiol. 39, 769\u2013782 (2019).","journal-title":"Cell. Mol. Neurobiol."},{"key":"2881_CR115","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1136\/jclinpath-2015-202868","volume":"68","author":"K Nordfors","year":"2015","unstructured":"Nordfors, K. et al. Twist predicts poor outcome of patients with astrocytic glioma. J. Clin. Pathol. 68, 905\u2013912 (2015).","journal-title":"J. Clin. Pathol."},{"key":"2881_CR116","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/s41388-024-02987-5","volume":"43","author":"V Kumar","year":"2024","unstructured":"Kumar, V. et al. TWIST1 is a critical downstream target of the HGF\/MET pathway and is required for MET driven acquired resistance in oncogene driven lung cancer. Oncogene 43, 1431\u20131444 (2024).","journal-title":"Oncogene"},{"key":"2881_CR117","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/path.6001","volume":"258","author":"HH Lai","year":"2022","unstructured":"Lai, H. H. et al. NEIL3 promotes hepatoma epithelial\u2013mesenchymal transition by activating the BRAF\/MEK\/ERK\/TWIST signaling pathway. J. Pathol. 258, 339\u2013352 (2022).","journal-title":"J. Pathol."},{"key":"2881_CR118","doi-asserted-by":"crossref","unstructured":"Sehgal, M. et al. Deciphering carcinogenic regulatory signatures through network motif\u2013driven pathway analysis for computational prioritization of candidate regulatory proteins. In Silico Res. Biomed. 100262, (2026).","DOI":"10.1016\/j.insi.2026.100262"},{"key":"2881_CR119","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13056","volume":"54","author":"K Liu","year":"2021","unstructured":"Liu, K. et al. A novel mouse model for liver metastasis of prostate cancer reveals dynamic tumour-immune cell communication. Cell Prolif. 54, e13056 (2021).","journal-title":"Cell Prolif."},{"key":"2881_CR120","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s11033-023-09167-w","volume":"51","author":"R Said","year":"2024","unstructured":"Said, R. et al. Co-expression of Twist and Snai1: predictor of poor prognosis and biomarker of treatment resistance in untreated prostate cancer. Mol. Biol. Rep. 51, 226 (2024).","journal-title":"Mol. Biol. Rep."},{"key":"2881_CR121","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41419-023-05596-4","volume":"14","author":"K Chen","year":"2023","unstructured":"Chen, K. et al. Rab31 promotes metastasis and cisplatin resistance in stomach adenocarcinoma through Twist1-mediated EMT. Cell Death Dis. 14, 115 (2023).","journal-title":"Cell Death Dis."},{"key":"2881_CR122","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/nar\/28.2.626","volume":"28","author":"H Kataoka","year":"2000","unstructured":"Kataoka, H. et al. A novel Snail-related transcription factor Smuc regulates basic helix\u2013loop\u2013helix transcription factor activities via specific E-box motifs. Nucleic acids Res. 28, 626\u2013633 (2000).","journal-title":"Nucleic acids Res."},{"key":"2881_CR123","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.exphem.2014.03.002","volume":"42","author":"PD Pioli","year":"2014","unstructured":"Pioli, P. D. & Weis, J. H. Snail transcription factors in hematopoietic cell development: a model of functional redundancy. Exp. Hematol. 42, 425\u2013430 (2014).","journal-title":"Exp. Hematol."},{"key":"2881_CR124","doi-asserted-by":"crossref","unstructured":"Recouvreux, M. V. et al. Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer. 217, e20200388, (2020).","DOI":"10.1084\/jem.20200388"},{"key":"2881_CR125","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/emboj.2010.349","volume":"30","author":"S Brabletz","year":"2011","unstructured":"Brabletz, S. et al. The ZEB1\/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J. 30, 770\u2013782 (2011).","journal-title":"EMBO J."},{"key":"2881_CR126","doi-asserted-by":"publisher","first-page":"1543096","DOI":"10.3389\/fimmu.2025.1543096","volume":"16","author":"C Xu","year":"2025","unstructured":"Xu, C., Chen, J., Tan, M. & Tan, Q. The role of macrophage polarization in ovarian cancer: From molecular mechanism to therapeutic potentials. Front. Immunol. 16, 1543096 (2025).","journal-title":"Front. Immunol."},{"key":"2881_CR127","doi-asserted-by":"crossref","unstructured":"Yang, Y. et al. Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy. 44, 145 (2025).","DOI":"10.1186\/s13046-025-03377-9"},{"key":"2881_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0421-2","volume":"14","author":"A Alsuliman","year":"2015","unstructured":"Alsuliman, A. et al. Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: significance in claudin-low breast cancer cells. Mol. Cancer 14, 149 (2015).","journal-title":"Mol. Cancer"},{"key":"2881_CR129","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/onc.2015.258","volume":"35","author":"MT Goswami","year":"2016","unstructured":"Goswami, M. T. et al. Regulation of complement-dependent cytotoxicity by TGF-\u03b2-induced epithelial\u2013mesenchymal transition. Oncogene 35, 1888\u20131898 (2016).","journal-title":"Oncogene"},{"key":"2881_CR130","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1172\/JCI97611","volume":"128","author":"PJ Chockley","year":"2018","unstructured":"Chockley, P. J. et al. Epithelial-mesenchymal transition leads to NK cell\u2013mediated metastasis-specific immunosurveillance in lung cancer. J. Clin. Investig. 128, 1384\u20131396 (2018).","journal-title":"J. Clin. Investig."},{"key":"2881_CR131","doi-asserted-by":"crossref","unstructured":"Heldin, C. H. & Moustakas, A. Signaling receptors for TGF-\u03b2 family members. Cold Spring Harbor Perspect. Biol. 8, (2016).","DOI":"10.1101\/cshperspect.a022053"},{"key":"2881_CR132","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3724\/abbs.2022132","volume":"55","author":"W Yang","year":"2022","unstructured":"Yang, W. et al. Single-cell analysis reveals that cancer-associated fibroblasts stimulate oral squamous cell carcinoma invasion via the TGF-\u03b2\/Smad pathway: Singel-cell sequencing reveals the role of CAFs in OSCC. Acta Biochim. Biophys. Sin. 55, 262 (2022).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"2881_CR133","doi-asserted-by":"crossref","unstructured":"Xu, J., Lamouille, S. & Derynck, R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19, 156\u2013172 (2009).","DOI":"10.1038\/cr.2009.5"},{"key":"2881_CR134","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.31756","volume":"7","author":"A Ramachandran","year":"2018","unstructured":"Ramachandran, A. et al. TGF-\u03b2 uses a novel mode of receptor activation to phosphorylate SMAD1\/5 and induce epithelial-to-mesenchymal transition. elife 7, e31756 (2018).","journal-title":"elife"},{"key":"2881_CR135","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.cell.2011.04.029","volume":"145","author":"C Scheel","year":"2011","unstructured":"Scheel, C. et al. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145, 926\u2013940 (2011).","journal-title":"Cell"},{"key":"2881_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111462","volume":"124","author":"Z Li","year":"2024","unstructured":"Li, Z. et al. CAF-secreted LOX promotes PD-L1 expression via histone Lactylation and regulates tumor EMT through TGF\u03b2\/IGF1 signaling in gastric Cancer. Cell. Signal. 124, 111462 (2024).","journal-title":"Cell. Signal."},{"key":"2881_CR137","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7150\/jca.102654","volume":"16","author":"X Zhao","year":"2025","unstructured":"Zhao, X. et al. MiR-675 Inhibits Primary Ovarian Tumor Growth and Metastasis by Suppressing EMT and TGF\u03b2 Signaling. J. Cancer 16, 55 (2025).","journal-title":"J. Cancer"},{"key":"2881_CR138","doi-asserted-by":"crossref","unstructured":"Abbasifarid, A., Dorostkar, R. & Ghalavand, M. miR-122 shows potential as a biomarker and therapeutic target in NSCLC by inhibiting WNT\/\u03b2-catenin and PI3K\/AKT pathways and key transcription factors linked to EMT and metastasis. Heliyon. 11, (2025).","DOI":"10.1016\/j.heliyon.2025.e42961"},{"key":"2881_CR139","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10142-024-01403-1","volume":"24","author":"X Yang","year":"2024","unstructured":"Yang, X. et al. TGF-\u03b21-Induced LINC01094 promotes epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-122-5p\/TGFBR2\u2013SAMD2\u2013SMAD3 Axis. Funct. Integr. Genomics 24, 123 (2024).","journal-title":"Funct. Integr. Genomics"},{"key":"2881_CR140","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10142-024-01442-8","volume":"24","author":"S Zhao","year":"2024","unstructured":"Zhao, S., Song, C., Chen, F. & Li, M. LncRNA XIST\/miR-455-3p\/HOXC4 axis promotes breast cancer development by activating TGF-\u03b2\/SMAD signaling pathway. Funct. Integr. Genomics 24, 159 (2024).","journal-title":"Funct. Integr. Genomics"},{"key":"2881_CR141","doi-asserted-by":"publisher","first-page":"e14489","DOI":"10.1111\/cns.14489","volume":"30","author":"WW Duan","year":"2024","unstructured":"Duan, W. W. et al. A TGF-\u03b2 signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response. CNS Neurosci. Ther. 30, e14489 (2024).","journal-title":"CNS Neurosci. Ther."},{"key":"2881_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00427-x","volume":"7","author":"SJ O\u2019Brien","year":"2021","unstructured":"O\u2019Brien, S. J. et al. Long non-coding RNA ZFAS1 is a major regulator of epithelial-mesenchymal transition through miR-200\/ZEB1\/E-cadherin, vimentin signaling in colon adenocarcinoma. Cell Death Discov. 7, 61 (2021).","journal-title":"Cell Death Discov."},{"key":"2881_CR143","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00018-016-2174-5","volume":"73","author":"SU Schmitz","year":"2016","unstructured":"Schmitz, S. U., Grote, P. & Herrmann, B. G. Mechanisms of long noncoding RNA function in development and disease. Cell. Mol. life Sci. 73, 2491\u20132509 (2016).","journal-title":"Cell. Mol. life Sci."},{"key":"2881_CR144","doi-asserted-by":"publisher","first-page":"135","DOI":"10.15252\/embr.201744250","volume":"19","author":"D Du","year":"2018","unstructured":"Du, D. et al. Smad3-mediated recruitment of the methyltransferase SETDB1\/ESET controls Snail1 expression and epithelial\u2013mesenchymal transition. EMBO Rep. 19, 135\u2013155 (2018).","journal-title":"EMBO Rep."},{"key":"2881_CR145","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1158\/0008-5472.CAN-20-2906","volume":"81","author":"D Strepkos","year":"2021","unstructured":"Strepkos, D. et al. Histone methyltransferase SETDB1: a common denominator of tumorigenesis with therapeutic potential. Cancer Res. 81, 525\u2013534 (2021).","journal-title":"Cancer Res."},{"key":"2881_CR146","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2174\/1568009622666220411112312","volume":"22","author":"Y Ren","year":"2022","unstructured":"Ren, Y. et al. EGF\/EGFR promotes salivary adenoid cystic carcinoma cell malignant neural invasion via activation of PI3K\/AKT and MEK\/ERK signaling. Curr. Cancer Drug Targets 22, 603\u2013616 (2022).","journal-title":"Curr. Cancer Drug Targets"},{"key":"2881_CR147","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41417-022-00530-w","volume":"30","author":"Q Wang","year":"2023","unstructured":"Wang, Q. et al. FUT6 inhibits the proliferation, migration, invasion, and EGF-induced EMT of head and neck squamous cell carcinoma (HNSCC) by regulating EGFR\/ERK\/STAT signaling pathway. Cancer Gene Ther. 30, 182\u2013191 (2023).","journal-title":"Cancer Gene Ther."},{"key":"2881_CR148","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/sj.bjc.6604794","volume":"100","author":"M Colomiere","year":"2009","unstructured":"Colomiere, M. et al. Cross talk of signals between EGFR and IL-6R through JAK2\/STAT3 mediate epithelial\u2013mesenchymal transition in ovarian carcinomas. Br. J. cancer 100, 134\u2013144 (2009).","journal-title":"Br. J. cancer"},{"key":"2881_CR149","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/bbb\/zbae132","volume":"88","author":"Y Take","year":"2024","unstructured":"Take, Y. et al. Epidermal growth factor induces the initiation of epithelial mesenchymal transition in high-density colorectal cancer cell culture. Biosci., Biotechnol., Biochem. 88, 1442\u20131448 (2024).","journal-title":"Biosci., Biotechnol., Biochem."},{"key":"2881_CR150","doi-asserted-by":"crossref","unstructured":"Uttamsingh, S. et al. Synergistic effect between EGF and TGF-\u03b21 in inducing oncogenic properties of intestinal epithelial cells. 27, 2626\u20132634 (2008).","DOI":"10.1038\/sj.onc.1210915"},{"key":"2881_CR151","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s10528-024-10784-8","volume":"63","author":"C Wang","year":"2025","unstructured":"Wang, C. et al. Cuproptosis-Related Gene FDX1 Suppresses the Growth and Progression of Colorectal Cancer by Retarding EMT Progress. Biochem Genet 63, 775\u2013788 (2025).","journal-title":"Biochem Genet"},{"key":"2881_CR152","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s10528-024-10784-8","volume":"63","author":"C Wang","year":"2025","unstructured":"Wang, C. et al. Cuproptosis-related gene FDX1 suppresses the growth and progression of colorectal cancer by retarding EMT progress. Biochem. Genet. 63, 775\u2013788 (2025).","journal-title":"Biochem. Genet."},{"key":"2881_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02380-5","volume":"11","author":"W Yang","year":"2025","unstructured":"Yang, W. et al. FDX1 overexpression inhibits the growth and metastasis of clear cell renal cell carcinoma by upregulating FMR1 expression. Cell Death Discov. 11, 115 (2025).","journal-title":"Cell Death Discov."},{"key":"2881_CR154","first-page":"1","volume":"2","author":"EA McNiel","year":"2017","unstructured":"McNiel, E. A. & Tsichlis, P. N. Analyses of publicly available genomics resources define FGF-2-expressing bladder carcinomas as EMT-prone, proliferative tumors with low mutation rates and high expression of CTLA-4, PD-1 and PD-L1. Signal Transduct. Target. Ther. 2, 1\u20138 (2017).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2881_CR155","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/carcin\/bgx095","volume":"38","author":"O Maehara","year":"2017","unstructured":"Maehara, O. et al. Fibroblast growth factor-2\u2013mediated FGFR\/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma. Carcinogenesis 38, 1073\u20131083 (2017).","journal-title":"Carcinogenesis"},{"key":"2881_CR156","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-02073-2","volume":"29","author":"AR Devan","year":"2024","unstructured":"Devan, A. R. et al. The role of glypican-3 in hepatocellular carcinoma: Insights into diagnosis and therapeutic potential. Eur. J. Med. Res. 29, 490 (2024).","journal-title":"Eur. J. Med. Res."},{"key":"2881_CR157","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/carcin\/bgx095","volume":"38","author":"O Maehara","year":"2017","unstructured":"Maehara, O. et al. Fibroblast growth factor-2-mediated FGFR\/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma. Carcinogenesis 38, 1073\u20131083 (2017).","journal-title":"Carcinogenesis"},{"key":"2881_CR158","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01276-5","volume":"19","author":"X Xu","year":"2020","unstructured":"Xu, X., Zhang, M., Xu, F. & Jiang, S. Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities. Mol. cancer 19, 165 (2020).","journal-title":"Mol. cancer"},{"key":"2881_CR159","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12672-021-00429-2","volume":"12","author":"K Sompel","year":"2021","unstructured":"Sompel, K., Elango, A., Smith, A .J. & Tennis, M. A. Cancer chemoprevention through Frizzled receptors and EMT. Discov. Oncol. 12, 32 (2021).","journal-title":"Discov. Oncol."},{"key":"2881_CR160","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrc3217","volume":"12","author":"EN Arwert","year":"2012","unstructured":"Arwert, E. N., Hoste, E. & Watt, F. M. Epithelial stem cells, wound healing and cancer. Nat. Rev. Cancer 12, 170\u2013180 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"2881_CR161","doi-asserted-by":"publisher","first-page":"re8","DOI":"10.1126\/scisignal.2005189","volume":"7","author":"DM Gonzalez","year":"2014","unstructured":"Gonzalez, D. M. & Medici, D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci. Signal. 7, re8\u2013re8 (2014).","journal-title":"Sci. Signal."},{"key":"2881_CR162","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature22334","volume":"545","author":"T Tammela","year":"2017","unstructured":"Tammela, T. et al. A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma. Nature 545, 355\u2013359 (2017).","journal-title":"Nature"},{"key":"2881_CR163","doi-asserted-by":"publisher","first-page":"995","DOI":"10.31557\/APJCP.2019.20.4.995","volume":"20","author":"Z Javed","year":"2019","unstructured":"Javed, Z. et al. Wnt signaling: a potential therapeutic target in head and neck squamous cell carcinoma. Asian Pac. J. Cancer Prev.: APJCP 20, 995 (2019).","journal-title":"Asian Pac. J. Cancer Prev.: APJCP"},{"key":"2881_CR164","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41575-022-00641-7","volume":"19","author":"K Ray","year":"2022","unstructured":"Ray, K. Crosstalk between enteric neurons and colorectal cancer stem cells influences self-renewal. Nat. Rev. Gastroenterol. Hepatol. 19, 416\u2013416 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2881_CR165","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle, E. & Clevers, H. Cancer stem cells revisited. Nat. Med. 23, 1124\u20131134 (2017).","journal-title":"Nat. Med."},{"key":"2881_CR166","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.canlet.2019.03.008","volume":"452","author":"I Pal","year":"2019","unstructured":"Pal, I. et al. Prevention of epithelial to mesenchymal transition in colorectal carcinoma by regulation of the E-cadherin-\u03b2-catenin-vinculin axis. Cancer Lett. 452, 254\u2013263 (2019).","journal-title":"Cancer Lett."},{"key":"2881_CR167","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1083\/jcb.143.2.523","volume":"143","author":"J Balsamo","year":"1998","unstructured":"Balsamo, J., Arregui, C., Leung, T. & Lilien, J. The nonreceptor protein tyrosine phosphatase PTP1B binds to the cytoplasmic domain of N-cadherin and regulates the cadherin\u2013actin linkage. J. Cell Biol. 143, 523\u2013532 (1998).","journal-title":"J. Cell Biol."},{"key":"2881_CR168","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1080\/01635581.2020.1800764","volume":"73","author":"S Sameri","year":"2021","unstructured":"Sameri, S., Saidijam, M., Bahreini, F. & Najafi, R. Cancer chemopreventive activities of silibinin on colorectal cancer through regulation of E-cadherin\/\u03b2-catenin pathway. Nutr. Cancer 73, 1389\u20131399 (2021).","journal-title":"Nutr. Cancer"},{"key":"2881_CR169","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.1002\/tox.24359","volume":"39","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Asiaticoside inhibits growth and metastasis in non-small cell lung cancer by disrupting EMT via Wnt\/\u03b2-Catenin pathway. Environ. Toxicol. 39, 4859\u20134870 (2024).","journal-title":"Environ. Toxicol."},{"key":"2881_CR170","doi-asserted-by":"publisher","first-page":"105746","DOI":"10.1016\/j.tiv.2023.105746","volume":"95","author":"X Yu","year":"2024","unstructured":"Yu, X., Li, Y., Kong, F. & Xu, Q. METTL3 regulates FAM83D m6A modification to accelerate tumorigenesis of triple-negative breast cancer via the Wnt\/\u03b2-catenin pathway. Toxicol. Vitr. 95, 105746 (2024).","journal-title":"Toxicol. Vitr."},{"key":"2881_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216596","volume":"582","author":"X Dai","year":"2024","unstructured":"Dai, X. et al. Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3\u03b2\/TCF7\/MMP9 pathway and synergies with capecitabine. Cancer Lett. 582, 216596 (2024).","journal-title":"Cancer Lett."},{"key":"2881_CR172","first-page":"139","volume":"40","author":"R Li","year":"2025","unstructured":"Li, R. et al. Dihydroartemisinin inhibits epithelial\u2013mesenchymal transition progression in medullary thyroid carcinoma through the hippo signaling pathway regulated by Interleukin-6. Cancer Biother. Radiopharm. 40, 139\u2013150 (2025).","journal-title":"Cancer Biother. Radiopharm."},{"key":"2881_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156156","volume":"135","author":"Z Ren","year":"2024","unstructured":"Ren, Z. et al. Yes-associated protein indispensably mediates hirsutine-induced inhibition on cell growth and Wnt\/\u03b2-catenin signaling in colorectal cancer. Phytomedicine 135, 156156 (2024).","journal-title":"Phytomedicine"},{"key":"2881_CR174","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13046-024-03107-7","volume":"43","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. The RP11-417E7. 1\/THBS2 signaling pathway promotes colorectal cancer metastasis by activating the Wnt\/\u03b2-catenin pathway and facilitating exosome-mediated M2 macrophage polarization. J. Exp. Clin. Cancer Res. 43, 195 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2881_CR175","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411869","volume":"12","author":"L Tang","year":"2025","unstructured":"Tang, L. et al. EIF4A3-mediated biogenesis of CircFADS1 promotes the progression of hepatocellular carcinoma via Wnt\/\u03b2-catenin pathway. Adv. Sci. 12, 2411869 (2025).","journal-title":"Adv. Sci."},{"key":"2881_CR176","doi-asserted-by":"crossref","unstructured":"VanderVorst, K. et al. Vangl-dependent Wnt\/planar cell polarity signaling mediates collective breast carcinoma motility and distant metastasis. 25, 52 (2023).","DOI":"10.1186\/s13058-023-01651-2"},{"key":"2881_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216280","volume":"567","author":"CA Dreyer","year":"2023","unstructured":"Dreyer, C. A. et al. A complex of Wnt\/planar cell polarity signaling components Vangl1 and Fzd7 drives glioblastoma multiforme malignant properties. Cancer Lett. 567, 216280 (2023).","journal-title":"Cancer Lett."},{"key":"2881_CR178","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrm.2016.94","volume":"17","author":"SJ Bray","year":"2016","unstructured":"Bray, S. J. Notch signalling in context. Nat. Rev. Mol. Cell Biol. 17, 722\u2013735 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2881_CR179","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1146\/annurev-pathol-052016-100127","volume":"12","author":"JC Aster","year":"2017","unstructured":"Aster, J. C., Pear, W. S. & Blacklow, S. C. The varied roles of notch in cancer. Annu. Rev. Pathol.: Mech. Dis. 12, 245\u2013275 (2017).","journal-title":"Annu. Rev. Pathol.: Mech. Dis."},{"key":"2881_CR180","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.3390\/ijms23105535","volume":"23","author":"N Goto","year":"2022","unstructured":"Goto, N. et al. Development of a novel Anti\u2212 CD44 monoclonal antibody for multiple applications against esophageal squamous cell carcinomas. Int. J. Mol. Sci. 23, 5535 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2881_CR181","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41419-020-03037-0","volume":"11","author":"C Yang","year":"2020","unstructured":"Yang, C. et al. CD44\/HA signaling mediates acquired resistance to a PI3K\u03b1 inhibitor. Cell Death Dis. 11, 831 (2020).","journal-title":"Cell Death Dis."},{"key":"2881_CR182","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01500-9","volume":"8","author":"M Natsuizaka","year":"2017","unstructured":"Natsuizaka, M. et al. Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma. Nat. Commun. 8, 1758 (2017).","journal-title":"Nat. Commun."},{"key":"2881_CR183","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","volume":"7","author":"B Zhou","year":"2022","unstructured":"Zhou, B. et al. Notch signaling pathway: architecture, disease, and therapeutics. Signal Transduct. Target. Ther. 7, 95 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2881_CR184","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1097\/01.ASN.0000017905.77985.4A","volume":"13","author":"J Morrissey","year":"2002","unstructured":"Morrissey, J. et al. Transforming growth factor-beta induces renal epithelial jagged-1 expression in fibrotic disease. J. Am. Soc. Nephrol. : JASN 13, 1499\u20131508 (2002).","journal-title":"J. Am. Soc. Nephrol. : JASN"},{"key":"2881_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115991","volume":"220","author":"M Feng","year":"2024","unstructured":"Feng, M. et al. Inhibition of \u03b3-secretase\/Notch pathway as a potential therapy for reversing cancer drug resistance. Biochem. Pharmacol. 220, 115991 (2024).","journal-title":"Biochem. Pharmacol."},{"key":"2881_CR186","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41594-024-01439-8","volume":"32","author":"X Guo","year":"2025","unstructured":"Guo, X. et al. Structural basis of human \u03b3-secretase inhibition by anticancer clinical compounds. Nat. Struct. Mol. Biol. 32, 719\u2013728 (2025).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2881_CR187","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s40164-024-00588-2","volume":"13","author":"MS Kim","year":"2024","unstructured":"Kim, M. S. et al. Disrupting Notch signaling related HES1 in myeloid cells reinvigorates antitumor T cell responses. Exp. Hematol. Oncol. 13, 122 (2024).","journal-title":"Exp. Hematol. Oncol."},{"key":"2881_CR188","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/mc.23848","volume":"64","author":"S Sarkar","year":"2025","unstructured":"Sarkar, S., Kandasamy, T. & Ghosh, S. S. Imatinib impedes EMT and notch signalling by inhibiting p300 acetyltransferase in breast cancer cells. Mol. Carcinogenes. 64, 344\u2013356 (2025).","journal-title":"Mol. Carcinogenes."},{"key":"2881_CR189","doi-asserted-by":"publisher","first-page":"7061","DOI":"10.1158\/0008-5472.CAN-11-1338","volume":"71","author":"YA Yoo","year":"2011","unstructured":"Yoo, Y. A. et al. Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer Res. 71, 7061\u20137070 (2011).","journal-title":"Cancer Res."},{"key":"2881_CR190","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1161\/CIRCULATIONAHA.105.603167","volume":"113","author":"J Asai","year":"2006","unstructured":"Asai, J. et al. Topical sonic hedgehog gene therapy accelerates wound healing in diabetes by enhancing endothelial progenitor cell\u2013mediated microvascular remodeling. Circulation 113, 2413\u20132424 (2006).","journal-title":"Circulation"},{"key":"2881_CR191","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1038\/onc.2009.220","volume":"28","author":"JM Bailey","year":"2009","unstructured":"Bailey, J. M., Mohr, A. M. & Hollingsworth, M. A. Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene 28, 3513\u20133525 (2009).","journal-title":"Oncogene"},{"key":"2881_CR192","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s00432-019-02987-z","volume":"145","author":"K Kitagawa","year":"2019","unstructured":"Kitagawa, K. et al. Possible correlation of sonic hedgehog signaling with epithelial\u2013mesenchymal transition in muscle-invasive bladder cancer progression. J. Cancer Res. Clin. Oncol. 145, 2261\u20132271 (2019).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"2881_CR193","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1158\/0008-5472.CAN-06-3281","volume":"67","author":"G Feldmann","year":"2007","unstructured":"Feldmann, G. et al. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res. 67, 2187\u20132196 (2007).","journal-title":"Cancer Res."},{"key":"2881_CR194","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1007\/s11033-020-05435-1","volume":"47","author":"N Jiang","year":"2020","unstructured":"Jiang, N. et al. Role of PI3K\/AKT pathway in cancer: the framework of malignant behavior. Mol. Biol. Rep. 47, 4587\u20134629 (2020).","journal-title":"Mol. Biol. Rep."},{"key":"2881_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.154010","volume":"237","author":"M Ebrahimi","year":"2022","unstructured":"Ebrahimi, M. et al. PI3K\/Akt\/mTOR signaling pathway in cancer stem cells. Pathol.-Res. Pract. 237, 154010 (2022).","journal-title":"Pathol.-Res. Pract."},{"key":"2881_CR196","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0368-y","volume":"32","author":"Z Ke","year":"2015","unstructured":"Ke, Z., Caiping, S., Qing, Z. & Xiaojing, W. Sonic hedgehog\u2013Gli1 signals promote epithelial\u2013mesenchymal transition in ovarian cancer by mediating PI3K\/AKT pathway. Med. Oncol. 32, 368 (2015).","journal-title":"Med. Oncol."},{"key":"2881_CR197","doi-asserted-by":"crossref","unstructured":"Wang, X. et al. Hedgehog\/Gli2 signaling triggers cell proliferation and metastasis via EMT and wnt\/\u03b2-catenin pathways in oral squamous cell carcinoma. Heliyon. 10, (2024).","DOI":"10.1016\/j.heliyon.2024.e36516"},{"key":"2881_CR198","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s11010-024-05104-y","volume":"480","author":"T Huang","year":"2025","unstructured":"Huang, T. et al. Transcription factor Yin Yang 1 enhances epithelial-mesenchymal transition, migration, and stemness of non-small cell lung cancer cells by targeting sonic hedgehog. Mol. Cell. Biochem. 480, 1831\u20131843 (2025).","journal-title":"Mol. Cell. Biochem."},{"key":"2881_CR199","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41416-019-0705-1","volume":"122","author":"E D\u2019Arcangelo","year":"2020","unstructured":"D\u2019Arcangelo, E., Wu, N. C., Cadavid, J. L. & McGuigan, A. P. The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome. Br. J. Cancer 122, 931\u2013942 (2020).","journal-title":"Br. J. Cancer"},{"key":"2881_CR200","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00404-021-06137-0","volume":"305","author":"L Xiao","year":"2022","unstructured":"Xiao, L. et al. Overexpression of TGF-\u03b21 and SDF-1 in cervical cancer-associated fibroblasts promotes cell growth, invasion and migration. Arch. Gynecol. Obstet. 305, 179\u2013192 (2022).","journal-title":"Arch. Gynecol. Obstet."},{"key":"2881_CR201","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1002\/cam4.2249","volume":"8","author":"Y Mezawa","year":"2019","unstructured":"Mezawa, Y. et al. CD26 expression is attenuated by TGF-\u03b2 and SDF-1 autocrine signaling on stromal myofibroblasts in human breast cancers. Cancer Med. 8, 3936\u20133948 (2019).","journal-title":"Cancer Med."},{"key":"2881_CR202","doi-asserted-by":"publisher","first-page":"1333839","DOI":"10.3389\/fonc.2023.1333839","volume":"13","author":"J Zheng","year":"2023","unstructured":"Zheng, J. & Hao, H. The importance of cancer-associated fibroblasts in targeted therapies and drug resistance in breast cancer. Front. Oncol. 13, 1333839 (2023).","journal-title":"Front. Oncol."},{"key":"2881_CR203","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41419-021-03509-x","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Cancer-associated fibroblast-derived SDF-1 induces epithelial-mesenchymal transition of lung adenocarcinoma via CXCR4\/\u03b2-catenin\/PPAR\u03b4 signalling. Cell Death Dis. 12, 214 (2021).","journal-title":"Cell Death Dis."},{"key":"2881_CR204","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1038\/onc.2017.159","volume":"36","author":"C Pistore","year":"2017","unstructured":"Pistore, C. et al. DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells. Oncogene 36, 5551\u20135566 (2017).","journal-title":"Oncogene"},{"key":"2881_CR205","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0994-2","volume":"18","author":"ME Fiori","year":"2019","unstructured":"Fiori, M. E. et al. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Mol. cancer 18, 70 (2019).","journal-title":"Mol. cancer"},{"key":"2881_CR206","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol. cancer 19, 43 (2020).","journal-title":"Mol. cancer"},{"key":"2881_CR207","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.7150\/thno.111625","volume":"15","author":"L Liu","year":"2025","unstructured":"Liu, L. et al. FOS-driven inflammatory CAFs promote colorectal cancer liver metastasis via the SFRP1-FGFR2-HIF1 axis. Theranostics 15, 4593 (2025).","journal-title":"Theranostics"},{"key":"2881_CR208","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s12013-024-01505-4","volume":"83","author":"Y Yao","year":"2025","unstructured":"Yao, Y., Lv, R., Dong, J. & Chen, Q. a. CAFs-derived TIAM1 Promotes OSCC Cell Growth and Metastasis by Regulating ZEB2. Cell Biochem. Biophys. 83, 729\u2013740 (2025).","journal-title":"Cell Biochem. Biophys."},{"key":"2881_CR209","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06236-5","volume":"23","author":"Y Lu","year":"2025","unstructured":"Lu, Y. et al. Single-cell and spatial transcriptome profiling reveal CTHRC1+ fibroblasts promote EMT through WNT5A signaling in colorectal cancer. J. Transl. Med. 23, 282 (2025).","journal-title":"J. Transl. Med."},{"key":"2881_CR210","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/09287329241291432","volume":"33","author":"N Kang","year":"2025","unstructured":"Kang, N. et al. Cancer-associated fibroblasts derived-exosomal circ_0076535 promotes esophageal squamous cell carcinoma progression. Technol. Health Care 33, 1088\u20131098 (2025).","journal-title":"Technol. Health Care"},{"key":"2881_CR211","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02180-y","volume":"23","author":"X Zhou","year":"2024","unstructured":"Zhou, X. et al. THBS2+ cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K\/AKT activation in colorectal cancer. Mol. Cancer 23, 282 (2024).","journal-title":"Mol. Cancer"},{"key":"2881_CR212","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70126","volume":"39","author":"W Yang","year":"2025","unstructured":"Yang, W. et al. Cancer-associated fibroblast-secreted exosomes regulate macrophage polarization in pancreatic cancer via the NOD1 pathway. J. Biochem. Mol. Toxicol. 39, e70126 (2025).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"2881_CR213","doi-asserted-by":"crossref","unstructured":"Batrash, F. et al. Paracrine regulation and immune system pathways in the inflammatory tumor microenvironment of lung cancer: insights into oncogenesis and immunotherapeutic strategies. 16, 1113 (2024).","DOI":"10.3390\/cancers16061113"},{"key":"2881_CR214","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12672-024-00949-7","volume":"15","author":"ZS Sayed","year":"2024","unstructured":"Sayed, Z. S. et al. Circulating tumor cells clusters and their role in Breast cancer metastasis: a review of literature. Discov. Oncol. 15, 94 (2024).","journal-title":"Discov. Oncol."},{"key":"2881_CR215","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/odi.15212","volume":"31","author":"J Liu","year":"2025","unstructured":"Liu, J. et al. TAM-Derived Exosomes Promote EMT by Upregulating lncRNA MIR4435-2HG in Head and Neck Cancer. Oral. Dis. 31, 1154\u20131164 (2025).","journal-title":"Oral. Dis."},{"key":"2881_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2024.106894","volume":"202","author":"H Shu","year":"2024","unstructured":"Shu, H. et al. Ultrasound-mediated nanobubbles loaded with STAT6 siRNA inhibit TGF-\u03b21-EMT axis in LUSC cells via overcoming the polarization of M2-TAMs. Eur. J. Pharm. Sci. 202, 106894 (2024).","journal-title":"Eur. J. Pharm. Sci."},{"key":"2881_CR217","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13046-024-02989-x","volume":"43","author":"Z Hu","year":"2024","unstructured":"Hu, Z. et al. IL6-STAT3-C\/EBP\u03b2-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma. J. Exp. Clin. Cancer Res. 43, 63 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2881_CR218","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.ymthe.2021.02.006","volume":"29","author":"C Yang","year":"2021","unstructured":"Yang, C. et al. Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis. Mol. Ther. 29, 2088\u20132107 (2021).","journal-title":"Mol. Ther."},{"key":"2881_CR219","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00949-y","volume":"9","author":"Y Jiang","year":"2025","unstructured":"Jiang, Y. et al. HDAC6 facilitates LUAD progression by inducing EMT and enhancing macrophage polarization towards the M2 phenotype. NPJ Precis. Oncol. 9, 150 (2025).","journal-title":"NPJ Precis. Oncol."},{"key":"2881_CR220","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114623","volume":"155","author":"H-X Gao","year":"2025","unstructured":"Gao, H.-X. et al. MiR-135a-5p\/STAT6-mediated EMT regulates IL-4 secretion in non-small cell lung cancer to affect M2-like TAM polarization. Int. Immunopharmacol. 155, 114623 (2025).","journal-title":"Int. Immunopharmacol."},{"key":"2881_CR221","first-page":"101791","volume":"11","author":"R Bhushan","year":"2026","unstructured":"Bhushan, R. et al. Nanobots in medicine and beyond: From targeted drug delivery to intelligent environmental remediation. Materials 11, 101791 (2026).","journal-title":"Materials"},{"key":"2881_CR222","doi-asserted-by":"crossref","unstructured":"Raue, R., Frank, A. C., Syed, S. N. & Br\u00fcne, B. Therapeutic targeting of MicroRNAs in the Tumor Microenvironment. Int. J. Mol. Sci. 22, (2021).","DOI":"10.3390\/ijms22042210"},{"key":"2881_CR223","doi-asserted-by":"publisher","first-page":"e1000083","DOI":"10.1080\/2162402X.2014.1000083","volume":"4","author":"L Goebel","year":"2015","unstructured":"Goebel, L. et al. CD4+ T cells potently induce epithelial-mesenchymal-transition in premalignant and malignant pancreatic ductal epithelial cells\u2013novel implications of CD4+ T cells in pancreatic cancer development. Oncoimmunology 4, e1000083 (2015).","journal-title":"Oncoimmunology"},{"key":"2881_CR224","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1158\/0008-5472.CAN-08-3343","volume":"69","author":"M Santisteban","year":"2009","unstructured":"Santisteban, M. et al. Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res. 69, 2887\u20132895 (2009).","journal-title":"Cancer Res."},{"key":"2881_CR225","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/cbin.10788","volume":"41","author":"L Zhu","year":"2017","unstructured":"Zhu, L. et al. M2 macrophages induce EMT through the TGF-\u03b2\/Smad2 signaling pathway. Cell Biol. Int. 41, 960\u2013968 (2017).","journal-title":"Cell Biol. Int."},{"key":"2881_CR226","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1380765","volume":"7","author":"S Li","year":"2018","unstructured":"Li, S. et al. Tumor-associated macrophages remodeling EMT and predicting survival in colorectal carcinoma. Oncoimmunology 7, e1380765 (2018).","journal-title":"Oncoimmunology"},{"key":"2881_CR227","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molimm.2017.06.018","volume":"90","author":"D Che","year":"2017","unstructured":"Che, D. et al. Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2\/PGE2\/\u03b2-catenin signalling pathway. Mol. Immunol. 90, 197\u2013210 (2017).","journal-title":"Mol. Immunol."},{"key":"2881_CR228","doi-asserted-by":"crossref","unstructured":"Li, W. et al. Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer. 10, 918 (2019).","DOI":"10.1038\/s41419-019-2131-y"},{"key":"2881_CR229","doi-asserted-by":"publisher","first-page":"1230681","DOI":"10.3389\/fimmu.2023.1230681","volume":"14","author":"J Gu","year":"2023","unstructured":"Gu, J. et al. Deciphering the mechanism of Peptostreptococcus anaerobius-induced chemoresistance in colorectal cancer: the important roles of MDSC recruitment and EMT activation. Front. Immunol. 14, 1230681 (2023).","journal-title":"Front. Immunol."},{"key":"2881_CR230","doi-asserted-by":"publisher","first-page":"e1001162","DOI":"10.1371\/journal.pbio.1001162","volume":"9","author":"B Toh","year":"2011","unstructured":"Toh, B. et al. Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol. 9, e1001162 (2011).","journal-title":"PLoS Biol."},{"key":"2881_CR231","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00432-007-0225-x","volume":"133","author":"JY Park","year":"2007","unstructured":"Park, J. Y. et al. CXCL5 overexpression is associated with late stage gastric cancer. J. Cancer Res. Clin. Oncol. 133, 835\u2013840 (2007).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"2881_CR232","doi-asserted-by":"publisher","first-page":"944494","DOI":"10.3389\/fonc.2022.944494","volume":"12","author":"J Deng","year":"2022","unstructured":"Deng, J., Jiang, R., Meng, E. & Wu, H. CXCL5: A coachman to drive cancer progression. Front. Oncol. 12, 944494 (2022).","journal-title":"Front. Oncol."},{"key":"2881_CR233","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010057","volume":"13","author":"RM Walsh","year":"2025","unstructured":"Walsh, R. M. et al. Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancreatic cancer. J. Immunother. Cancer 13, e010057 (2025).","journal-title":"J. Immunother. Cancer"},{"key":"2881_CR234","doi-asserted-by":"publisher","first-page":"13358","DOI":"10.3390\/ijms222413358","volume":"22","author":"M Sisto","year":"2021","unstructured":"Sisto, M., Ribatti, D. & Lisi, S. Cadherin signaling in cancer and autoimmune diseases. Int. J. Mol. Sci. 22, 13358 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"2881_CR235","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial\u2013mesenchymal transition. Nat. Rev. Mol. cell Biol. 15, 178\u2013196 (2014).","journal-title":"Nat. Rev. Mol. cell Biol."},{"key":"2881_CR236","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/mc.22994","volume":"58","author":"I Yalim-Camci","year":"2019","unstructured":"Yalim-Camci, I. et al. ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors. Mol. Carcinogenes. 58, 1068\u20131081 (2019).","journal-title":"Mol. Carcinogenes."},{"key":"2881_CR237","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1158\/0008-5472.CAN-07-2706","volume":"68","author":"M Labelle","year":"2008","unstructured":"Labelle, M. et al. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor \u03b2 signaling. Cancer Res. 68, 1388\u20131397 (2008).","journal-title":"Cancer Res."},{"key":"2881_CR238","doi-asserted-by":"publisher","first-page":"36570","DOI":"10.1074\/jbc.C110.164442","volume":"285","author":"Q Fan","year":"2010","unstructured":"Fan, Q. et al. Requirement of TGF\u03b2 signaling for SMO-mediated carcinogenesis. J. Biol. Chem. 285, 36570\u201336576 (2010).","journal-title":"J. Biol. Chem."},{"key":"2881_CR239","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/carcin\/bgm281","volume":"29","author":"YA Yoo","year":"2008","unstructured":"Yoo, Y. A., Kang, M. H., Kim, J. S. & Oh, S. C. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-\u03b2-mediated activation of the ALK5\u2013Smad 3 pathway. Carcinogenesis 29, 480\u2013490 (2008).","journal-title":"Carcinogenesis"},{"key":"2881_CR240","doi-asserted-by":"publisher","first-page":"189540","DOI":"10.1016\/j.bbcan.2026.189540","volume":"1881","author":"GS Kakde","year":"2026","unstructured":"Kakde, G. S., Dakal, T. C. & Maurya, P. K. Emerging multi-omics biomarkers in glioblastoma: Integrative insights from genomics to metabolomics. Biochimica et. Biophysica Acta (BBA) - Rev. Cancer 1881, 189540 (2026).","journal-title":"Biochimica et. Biophysica Acta (BBA) - Rev. Cancer"},{"key":"2881_CR241","doi-asserted-by":"crossref","unstructured":"Islam, S. et al. Sonic hedgehog (SHH) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer. 55, 537\u2013551 (2016).","DOI":"10.1002\/mc.22300"},{"key":"2881_CR242","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm3434","volume":"13","author":"J Massagu\u00e9","year":"2012","unstructured":"Massagu\u00e9, J. TGF\u03b2 signalling in context. Nat. Rev. Mol. Cell Biol. 13, 616\u2013630 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2881_CR243","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.1158\/0008-5472.CAN-14-0225","volume":"74","author":"SN Steinway","year":"2014","unstructured":"Steinway, S. N. et al. Network modeling of TGF\u03b2 signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activation. Cancer Res. 74, 5963\u20135977 (2014).","journal-title":"Cancer Res."},{"key":"2881_CR244","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1126\/science.1094291","volume":"303","author":"WJ Nelson","year":"2004","unstructured":"Nelson, W. J. & Nusse, R. Convergence of Wnt, \u00df-catenin, and cadherin pathways. Science 303, 1483\u20131487 (2004).","journal-title":"Science"},{"key":"2881_CR245","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3389\/fonc.2019.01481","volume":"9","author":"C Li","year":"2020","unstructured":"Li, C. et al. The interaction of CDH20 with \u03b2-catenin inhibits cervical cancer cell migration and invasion via TGF-\u03b2\/smad\/SNAIL mediated EMT. Front. Oncol. 9, 1481 (2020).","journal-title":"Front. Oncol."},{"key":"2881_CR246","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1007\/s11010-021-04174-6","volume":"476","author":"M El Sabeh","year":"2021","unstructured":"El Sabeh, M. et al. Wnt\/\u03b2-catenin signaling pathway in uterine leiomyoma: role in tumor biology and targeting opportunities. Mol. Cell. Biochem. 476, 3513\u20133536 (2021).","journal-title":"Mol. Cell. Biochem."},{"key":"2881_CR247","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.1038\/s41388-020-1307-3","volume":"39","author":"W-J Huang","year":"2020","unstructured":"Huang, W.-J. et al. The \u03b2-catenin\/TCF-4-LINC01278-miR-1258-Smad2\/3 axis promotes hepatocellular carcinoma metastasis. Oncogene 39, 4538\u20134550 (2020).","journal-title":"Oncogene"},{"key":"2881_CR248","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00018-023-05099-7","volume":"81","author":"W Xue","year":"2024","unstructured":"Xue, W. et al. Wnt\/\u03b2-catenin-driven EMT regulation in human cancers. Cell. Mol. Life Sci. 81, 79 (2024).","journal-title":"Cell. Mol. Life Sci."},{"key":"2881_CR249","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41419-019-1429-0","volume":"10","author":"E-K Breuer","year":"2019","unstructured":"Breuer, E.-K. et al. Potassium channel activity controls breast cancer metastasis by affecting \u03b2-catenin signaling. Cell Death Dis. 10, 180 (2019).","journal-title":"Cell Death Dis."},{"key":"2881_CR250","volume":"2012","author":"M Nager","year":"2012","unstructured":"Nager, M. et al. \u03b2-catenin signalling in glioblastoma multiforme and glioma-initiating cells. Chemother. Res. Pract. 2012, 192362 (2012).","journal-title":"Chemother. Res. Pract."},{"key":"2881_CR251","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3390\/ijms23031353","volume":"23","author":"A Barzegar Behrooz","year":"2022","unstructured":"Barzegar Behrooz, A. et al. Wnt and PI3K\/Akt\/mTOR survival pathways as therapeutic targets in glioblastoma. Int. J. Mol. Sci. 23, 1353 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2881_CR252","doi-asserted-by":"crossref","unstructured":"Colella, B. et al. Autophagy induction impairs Wnt\/\u03b2-catenin signalling through \u03b2-catenin relocalisation in glioblastoma cells. 53, 357\u2013364 (2019).","DOI":"10.1016\/j.cellsig.2018.10.017"},{"key":"2881_CR253","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10565-019-09502-7","volume":"36","author":"VS Tomar","year":"2020","unstructured":"Tomar, V. S., Patil, V. & Somasundaram, K. Temozolomide induces activation of Wnt\/\u03b2-catenin signaling in glioma cells via PI3K\/Akt pathway: implications in glioma therapy. Cell Biol. Toxicol. 36, 273\u2013278 (2020).","journal-title":"Cell Biol. Toxicol."},{"key":"2881_CR254","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.cellsig.2011.12.009","volume":"24","author":"TD King","year":"2012","unstructured":"King, T. D., Zhang, W., Suto, M. J. & Li, Y. Frizzled7 as an emerging target for cancer therapy. Cell. Signal. 24, 846\u2013851 (2012).","journal-title":"Cell. Signal."},{"key":"2881_CR255","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7150\/ijbs.23756","volume":"14","author":"G Li","year":"2018","unstructured":"Li, G. et al. Frizzled7 promotes epithelial-to-mesenchymal transition and stemness via activating canonical Wnt\/\u03b2-catenin pathway in gastric cancer. Int. J. Biol. Sci. 14, 280 (2018).","journal-title":"Int. J. Biol. Sci."},{"key":"2881_CR256","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.canlet.2012.03.039","volume":"323","author":"H Zhang","year":"2012","unstructured":"Zhang, H. et al. Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt\/\u03b2-catenin pathway. Cancer Lett. 323, 106\u2013113 (2012).","journal-title":"Cancer Lett."},{"key":"2881_CR257","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/CAD.0000000000000236","volume":"26","author":"H Zhang","year":"2015","unstructured":"Zhang, H. et al. Suppression of multidrug resistance by rosiglitazone treatment in human ovarian cancer cells through downregulation of FZD1 and MDR1 genes. Anti-Cancer Drugs 26, 706\u2013715 (2015).","journal-title":"Anti-Cancer Drugs"},{"key":"2881_CR258","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1158\/0008-5472.CAN-10-1495","volume":"71","author":"X Jin","year":"2011","unstructured":"Jin, X. et al. Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation. Cancer Res. 71, 3066\u20133075 (2011).","journal-title":"Cancer Res."},{"key":"2881_CR259","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbamcr.2003.12.002","volume":"1691","author":"A Oloumi","year":"2004","unstructured":"Oloumi, A., McPhee, T. & Dedhar, S. Regulation of E-cadherin expression and \u03b2-catenin\/Tcf transcriptional activity by the integrin-linked kinase. Biochim. Biophys. Acta (BBA)-Mol. Cell Res. 1691, 1\u201315 (2004).","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"key":"2881_CR260","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1172\/JCI200317913","volume":"112","author":"Y Li","year":"2003","unstructured":"Li, Y. et al. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J. Clin. Investig. 112, 503\u2013516 (2003).","journal-title":"J. Clin. Investig."},{"key":"2881_CR261","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0092-8674(03)00234-4","volume":"113","author":"N Fujita","year":"2003","unstructured":"Fujita, N. et al. MTA3, a Mi-2\/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113, 207\u2013219 (2003).","journal-title":"Cell"},{"key":"2881_CR262","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.tem.2004.10.003","volume":"15","author":"KM Taylor","year":"2004","unstructured":"Taylor, K. M., Hiscox, S. & Nicholson, R. I. Zinc transporter LIV-1: a link between cellular development and cancer progression. Trends Endocrinol. Metab. 15, 461\u2013463 (2004).","journal-title":"Trends Endocrinol. Metab."},{"key":"2881_CR263","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano, A. et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol. Cancer 22, 138 (2023).","journal-title":"Mol. Cancer"},{"key":"2881_CR264","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/cimb47030155","volume":"47","author":"L Wu","year":"2025","unstructured":"Wu, L. et al. SJB2-043, a USP1 inhibitor, suppresses A549 cell proliferation, migration, and EMT via modulation of PI3K\/AKT\/mTOR, MAPK, and Wnt signaling pathways. Curr. Issues Mol. Biol. 47, 155 (2025).","journal-title":"Curr. Issues Mol. Biol."},{"key":"2881_CR265","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.108024","volume":"301","author":"Z Li","year":"2025","unstructured":"Li, Z. et al. Transcription factor TCF7L1 targeting HSPB6 is involved in EMT and PI3K\/AKT\/mTOR pathways in bladder cancer. J. Biol. Chem. 301, 108024 (2025).","journal-title":"J. Biol. Chem."},{"key":"2881_CR266","first-page":"94","volume":"16","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Magnolol and 5-fluorouracil synergy inhibition of metastasis of cervical cancer cells by targeting PI3K\/AKT\/mTOR and EMT pathways. Chin. Herb. Med. 16, 94\u2013105 (2024).","journal-title":"Chin. Herb. Med."},{"key":"2881_CR267","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113864","volume":"434","author":"X Ma","year":"2024","unstructured":"Ma, X. et al. Deubiquitinating enzyme OTUD4 regulates metastasis in triple-negative breast cancer by stabilizing Snail1. Exp. Cell Res. 434, 113864 (2024).","journal-title":"Exp. Cell Res."},{"key":"2881_CR268","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41419-024-06569-x","volume":"15","author":"M Ci","year":"2024","unstructured":"Ci, M. et al. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway. Cell Death Dis. 15, 179 (2024).","journal-title":"Cell Death Dis."},{"key":"2881_CR269","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s13402-023-00779-9","volume":"46","author":"B Zhao","year":"2023","unstructured":"Zhao, B. et al. USP13 promotes breast cancer metastasis through FBXL14-induced Twist1 ubiquitination. Cell. Oncol. 46, 717\u2013733 (2023).","journal-title":"Cell. Oncol."},{"key":"2881_CR270","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1335374","volume":"15","author":"N Zhang","year":"2024","unstructured":"Zhang, N. et al. Evaluation of the lncRNA-miRNA-mRNA ceRNA network in lungs of miR-147\u2212\/\u2212 mice. Front. Pharmacol. 15, 1335374 (2024).","journal-title":"Front. Pharmacol."},{"key":"2881_CR271","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41419-019-1591-4","volume":"10","author":"D-M Wu","year":"2019","unstructured":"Wu, D. -M. et al. The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K\/AKT signaling. Cell Death Dis. 10, 349 (2019).","journal-title":"Cell Death Dis."},{"key":"2881_CR272","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3892\/mmr.2022.12595","volume":"25","author":"H Liao","year":"2022","unstructured":"Liao, H. et al. B7-H3 promotes the epithelial-mesenchymal transition of NSCLC by targeting SIRT1 through the PI3K\/AKT pathway. Mol. Med. Rep. 25, 79 (2022).","journal-title":"Mol. Med. Rep."},{"key":"2881_CR273","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.biocel.2017.12.002","volume":"94","author":"H Wang","year":"2018","unstructured":"Wang, H. et al. Overexpression of ELF3 facilitates cell growth and metastasis through PI3K\/Akt and ERK signaling pathways in non-small cell lung cancer. Int. J. Biochem. Cell Biol. 94, 98\u2013106 (2018).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2881_CR274","doi-asserted-by":"crossref","unstructured":"Wang, Z. et al. PIK3CA is regulated by CUX1, promotes cell growth and metastasis in bladder cancer via activating epithelial-mesenchymal transition. 10, 536072 (2020).","DOI":"10.3389\/fonc.2020.536072"},{"key":"2881_CR275","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3390\/cells13100864","volume":"13","author":"M Ho","year":"2024","unstructured":"Ho, M. & Bonavida, B. Cross-Talks between Raf Kinase Inhibitor Protein and Programmed Cell Death Ligand 1 Expressions in Cancer: Role in Immune Evasion and Therapeutic Implications. Cells 13, 864 (2024).","journal-title":"Cells"},{"key":"2881_CR276","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s13046-022-02477-0","volume":"41","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K\/AKT signaling in tumor cells and phenotypic polarization of macrophages. J. Exp. Clin. Cancer Res. 41, 303 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2881_CR277","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41419-025-07690-1","volume":"16","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. PCSK9 promotes progression of anaplastic thyroid cancer through E-cadherin endocytosis. Cell Death Dis. 16, 362 (2025).","journal-title":"Cell Death Dis."},{"key":"2881_CR278","doi-asserted-by":"publisher","first-page":"e28086","DOI":"10.4161\/jkst.28086","volume":"3","author":"Y Teng","year":"2014","unstructured":"Teng, Y., Ross, J. L. & Cowell, J. K. The involvement of JAK-STAT3 in cell motility, invasion, and metastasis. Jak.-stat. 3, e28086 (2014).","journal-title":"Jak.-stat."},{"key":"2881_CR279","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106362","volume":"183","author":"R Roskoski Jr","year":"2022","unstructured":"Roskoski, R. Jr Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders. Pharmacol. Res. 183, 106362 (2022).","journal-title":"Pharmacol. Res."},{"key":"2881_CR280","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.tem.2023.08.001","volume":"34","author":"ST Orange","year":"2023","unstructured":"Orange, S. T. et al. The exercise IL-6 enigma in cancer. Trends Endocrinol. Metab. 34, 749\u2013763 (2023).","journal-title":"Trends Endocrinol. Metab."},{"key":"2881_CR281","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.7150\/ijbs.31999","volume":"15","author":"X Zheng","year":"2019","unstructured":"Zheng, X., Lu, G., Yao, Y. & Gu, W. An autocrine IL-6\/IGF-1R loop mediates EMT and promotes tumor growth in non-small cell lung cancer. Int. J. Biol. Sci. 15, 1882 (2019).","journal-title":"Int. J. Biol. Sci."},{"key":"2881_CR282","doi-asserted-by":"crossref","unstructured":"Kopantzev, E. et al. Activation of IGF\/IGF-IR signaling pathway fails to induce epithelial-mesenchymal transition in pancreatic cancer cells. 19, 390\u2013396 (2019).","DOI":"10.1016\/j.pan.2019.01.010"},{"key":"2881_CR283","doi-asserted-by":"crossref","unstructured":"Assaraf, Y. G. et al. The multi-factorial nature of clinical multidrug resistance in cancer. 46, 100645 (2019).","DOI":"10.1016\/j.drup.2019.100645"},{"key":"2881_CR284","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/j.xphs.2020.03.008","volume":"109","author":"H Kamioka","year":"2020","unstructured":"Kamioka, H. et al. Moesin-mediated P-glycoprotein activation during snail-induced epithelial-mesenchymal transition in lung cancer cells. J. Pharm. Sci. 109, 2302\u20132308 (2020).","journal-title":"J. Pharm. Sci."},{"key":"2881_CR285","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1038\/cddis.2011.61","volume":"2","author":"M Saxena","year":"2011","unstructured":"Saxena, M., Stephens, M. A., Pathak, H. & Rangarajan, A. Transcription factors that mediate epithelial\u2013mesenchymal transition lead to multidrug resistance by upregulating ABC transporters. Cell Death Dis. 2, e179\u2013e179 (2011).","journal-title":"Cell Death Dis."},{"key":"2881_CR286","unstructured":"Wang, X., Eichhorn, P. J. A. & Thiery, J. P. in Seminars in Cancer Biology. 1\u201311 (Elsevier)."},{"key":"2881_CR287","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12272-018-01108-7","volume":"42","author":"ES Cho","year":"2019","unstructured":"Cho, E. S., Kang, H. E., Kim, N. H. & Yook, J. I. Therapeutic implications of cancer epithelial-mesenchymal transition (EMT) ES Cho et al. Arch. Pharmacal. Res. 42, 14\u201324 (2019).","journal-title":"Arch. Pharmacal. Res."},{"key":"2881_CR288","doi-asserted-by":"publisher","first-page":"8563","DOI":"10.3390\/ijms21228563","volume":"21","author":"I G\u00f6tting","year":"2020","unstructured":"G\u00f6tting, I., Jendrossek, V. & Matschke, J. A new twist in protein kinase B\/Akt signaling: role of altered cancer cell metabolism in Akt-mediated therapy resistance. Int. J. Mol. Sci. 21, 8563 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"2881_CR289","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","volume":"38","author":"P Icard","year":"2018","unstructured":"Icard, P. et al. How the Warburg effect supports aggressiveness and drug resistance of cancer cells? Drug Resist. Updates 38, 1\u201311 (2018).","journal-title":"Drug Resist. Updates"},{"key":"2881_CR290","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.canlet.2014.04.001","volume":"356","author":"J Lu","year":"2015","unstructured":"Lu, J., Tan, M. & Cai, Q. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Lett. 356, 156\u2013164 (2015).","journal-title":"Cancer Lett."},{"key":"2881_CR291","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00280-018-3697-2","volume":"82","author":"Y He","year":"2018","unstructured":"He, Y. et al. FOXC2 promotes epithelial\u2013mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells. Cancer Chemother. Pharmacol. 82, 1049\u20131059 (2018).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"2881_CR292","doi-asserted-by":"publisher","first-page":"7559","DOI":"10.1128\/MCB.24.17.7559-7566.2004","volume":"24","author":"M Kajita","year":"2004","unstructured":"Kajita, M., McClinic, K. N. & Wade, P. A. Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress. Mol. Cell. Biol. 24, 7559\u20137566 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"2881_CR293","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.lungcan.2008.02.007","volume":"62","author":"W Zhuo","year":"2008","unstructured":"Zhuo, W. et al. Knockdown of Snail, a novel zinc finger transcription factor, via RNA interference increases A549 cell sensitivity to cisplatin via JNK\/mitochondrial pathway. Lung Cancer 62, 8\u201314 (2008).","journal-title":"Lung Cancer"},{"key":"2881_CR294","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3724\/abbs.2024106","volume":"56","author":"Y Diao","year":"2024","unstructured":"Diao, Y. et al. CCL2 promotes EGFR-TKIs resistance in non-small cell lung cancer via the AKT-EMT pathway: CCL2 and EGFR-TKIs resistance in NSCLC. Acta Biochim. Biophys. Sin. 56, 1549 (2024).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"2881_CR295","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3390\/genes15121624","volume":"15","author":"N Kobayashi","year":"2024","unstructured":"Kobayashi, N. et al. The impact of bevacizumab and miR200c on EMT and EGFR-TKI resistance in EGFR-mutant lung cancer organoids. Genes 15, 1624 (2024).","journal-title":"Genes"},{"key":"2881_CR296","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41419-024-06945-7","volume":"15","author":"N Li","year":"2024","unstructured":"Li, N. et al. PD-L1 induces autophagy and primary resistance to EGFR\u2013TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway. Cell Death Dis. 15, 555 (2024).","journal-title":"Cell Death Dis."},{"key":"2881_CR297","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/15384101.2015.1006048","volume":"14","author":"P Zhang","year":"2015","unstructured":"Zhang, P., Sun, Y. & Ma, L. Z. E. B. 1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance. Cell Cycle 14, 481\u2013487 (2015).","journal-title":"Cell Cycle"},{"key":"2881_CR298","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000493864","volume":"63","author":"Y Cui","year":"2019","unstructured":"Cui, Y. et al. ZEB1 promotes chemoresistance to cisplatin in ovarian cancer cells by suppressing SLC3A2. Chemotherapy 63, 262\u2013271 (2019).","journal-title":"Chemotherapy"},{"key":"2881_CR299","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41419-017-0087-3","volume":"9","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM. Cell Death Dis. 9, 57 (2018).","journal-title":"Cell Death Dis."},{"key":"2881_CR300","doi-asserted-by":"publisher","first-page":"460","DOI":"10.4103\/aja.aja_1_19","volume":"21","author":"O Orellana-Serradell","year":"2019","unstructured":"Orellana-Serradell, O., Herrera, D., Castellon, E. A. & Contreras, H. R. The transcription factor ZEB1 promotes chemoresistance in prostate cancer cell lines. Asian J. Androl. 21, 460\u2013467 (2019).","journal-title":"Asian J. Androl."},{"key":"2881_CR301","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/ncb3013","volume":"16","author":"P Zhang","year":"2014","unstructured":"Zhang, P. et al. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat. Cell Biol. 16, 864\u2013875 (2014).","journal-title":"Nat. Cell Biol."},{"key":"2881_CR302","unstructured":"Song, X. F. et al. ZEB1 promotes prostate cancer proliferation and invasion through ERK1\/2 signaling pathway. Eur. Rev. Med. Pharmacol. Sci. 21, (2017)."},{"key":"2881_CR303","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/1878-0261.12030","volume":"11","author":"K Hanrahan","year":"2017","unstructured":"Hanrahan, K. et al. The role of epithelial\u2013mesenchymal transition drivers ZEB 1 and ZEB 2 in mediating docetaxel-resistant prostate cancer. Mol. Oncol. 11, 251\u2013265 (2017).","journal-title":"Mol. Oncol."},{"key":"2881_CR304","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110792","volume":"109","author":"Y Jiang","year":"2023","unstructured":"Jiang, Y. et al. MicroRNA-142-3P suppresses the progression of papillary thyroid carcinoma by targeting FN1 and inactivating FAK\/ERK\/PI3K signaling. Cell. Signal. 109, 110792 (2023).","journal-title":"Cell. Signal."},{"key":"2881_CR305","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2022.101767","volume":"76","author":"G Liu","year":"2022","unstructured":"Liu, G. et al. FGA inhibits metastases and induces autophagic cell death in gastric cancer via inhibiting ITGA5 to regulate the FAK\/ERK pathway. Tissue Cell 76, 101767 (2022).","journal-title":"Tissue Cell"},{"key":"2881_CR306","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1038\/s41401-024-01312-w","volume":"45","author":"M-s Xu","year":"2024","unstructured":"Xu, M. -s et al. A novel FAK-degrading PROTAC molecule exhibited both anti-tumor activities and efficient MDR reversal effects. Acta Pharmacol. Sin. 45, 2174\u20132185 (2024).","journal-title":"Acta Pharmacol. Sin."},{"key":"2881_CR307","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.7150\/jca.101555","volume":"16","author":"M Li","year":"2025","unstructured":"Li, M. et al. KLK7 involvement in thyroid papillary carcinoma cell migration and invasion by EMT via MAPK\/ERK pathways. J. Cancer 16, 1709 (2025).","journal-title":"J. Cancer"},{"key":"2881_CR308","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s12672-024-01596-8","volume":"15","author":"L Wei","year":"2024","unstructured":"Wei, L. et al. PTEN inhibits epithelial mesenchymal transition of thyroid cancer cells by regulating the Wnt\/\u03b2-Catenin signaling pathway. Discov. Oncol. 15, 803 (2024).","journal-title":"Discov. Oncol."},{"key":"2881_CR309","doi-asserted-by":"publisher","first-page":"8264","DOI":"10.3390\/ijms25158264","volume":"25","author":"S Gupta","year":"2024","unstructured":"Gupta, S. et al. LncRNA PTENP1\/miR-21\/PTEN axis modulates EMT and drug resistance in cancer: dynamic boolean modeling for cell fates in DNA damage response. Int. J. Mol. Sci. 25, 8264 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"2881_CR310","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000616","volume":"9","author":"S Zhang","year":"2025","unstructured":"Zhang, S. et al. CD63-high macrophage-derived exosomal miR-6876-5p promotes hepatocellular carcinoma stemness via PTEN\/Akt-mediated EMT pathway. Hepatol. Commun. 9, e0616 (2025).","journal-title":"Hepatol. Commun."},{"key":"2881_CR311","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41419-024-06635-4","volume":"15","author":"J Wu","year":"2024","unstructured":"Wu, J. et al. FBXO32-mediated degradation of PTEN promotes lung adenocarcinoma progression. Cell Death Dis. 15, 282 (2024).","journal-title":"Cell Death Dis."},{"key":"2881_CR312","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-023-05838-7","volume":"616","author":"M Debaugnies","year":"2023","unstructured":"Debaugnies, M. et al. RHOJ controls EMT-associated resistance to chemotherapy. Nature 616, 168\u2013175 (2023).","journal-title":"Nature"},{"key":"2881_CR313","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s11033-024-09794-x","volume":"51","author":"HHA Khair","year":"2024","unstructured":"Khair, H. H. A. & Karag\u00f6z, I. D. MiR-21-5p knockdown inhibits epithelial to mesenchymal transition in A549 lung adenocarcinoma cells by upregulating RhoB. Mol. Biol. Rep. 51, 837 (2024).","journal-title":"Mol. Biol. Rep."},{"key":"2881_CR314","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.canlet.2012.08.013","volume":"326","author":"SC Jahn","year":"2012","unstructured":"Jahn, S. C. et al. An in vivo model of epithelial to mesenchymal transition reveals a mitogenic switch. Cancer Lett. 326, 183\u2013190 (2012).","journal-title":"Cancer Lett."},{"key":"2881_CR315","doi-asserted-by":"publisher","first-page":"11271","DOI":"10.1158\/0008-5472.CAN-06-2044","volume":"66","author":"CL Chaffer","year":"2006","unstructured":"Chaffer, C. L. et al. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res. 66, 11271\u201311278 (2006).","journal-title":"Cancer Res."},{"key":"2881_CR316","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/pros.21278","volume":"71","author":"CO Marian","year":"2011","unstructured":"Marian, C. O. et al. Evidence of epithelial to mesenchymal transition associated with increased tumorigenic potential in an immortalized normal prostate epithelial cell line. Prostate 71, 626\u2013636 (2011).","journal-title":"Prostate"},{"key":"2881_CR317","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ccr.2012.10.012","volume":"22","author":"OH Oca\u00f1a","year":"2012","unstructured":"Oca\u00f1a, O. H. et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22, 709\u2013724 (2012).","journal-title":"Cancer Cell"},{"key":"2881_CR318","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.ccr.2012.09.022","volume":"22","author":"JH Tsai","year":"2012","unstructured":"Tsai, J. H. et al. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22, 725\u2013736 (2012).","journal-title":"Cancer Cell"},{"key":"2881_CR319","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3473","volume":"15","author":"K Oh","year":"2013","unstructured":"Oh, K. et al. A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model. Breast Cancer Res. 15, R79 (2013).","journal-title":"Breast Cancer Res."},{"key":"2881_CR320","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13046-021-02006-5","volume":"40","author":"Q Li","year":"2021","unstructured":"Li, Q. et al. Inhibiting the redox function of APE1 suppresses cervical cancer metastasis via disengagement of ZEB1 from E-cadherin in EMT. J. Exp. Clin. Cancer Res. 40, 220 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2881_CR321","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ymeth.2025.11.007","volume":"246","author":"GK Manjunath","year":"2026","unstructured":"Manjunath, G. K. et al. From sample to clinical insight: a review of exome sequencing in disease diagnostics. Methods 246, 12\u201333 (2026).","journal-title":"Methods"},{"key":"2881_CR322","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.omto.2021.04.001","volume":"21","author":"G Sun","year":"2021","unstructured":"Sun, G. et al. Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges. Mol. Ther. Oncolyt. 21, 183\u2013206 (2021).","journal-title":"Mol. Ther. Oncolyt."},{"key":"2881_CR323","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36439-7","volume":"14","author":"G Malagoli Tagliazucchi","year":"2023","unstructured":"Malagoli Tagliazucchi, G., Wiecek, A. J., Withnell, E. & Secrier, M. Genomic and microenvironmental heterogeneity shaping epithelial-to-mesenchymal trajectories in cancer. Nat. Commun. 14, 789 (2023).","journal-title":"Nat. Commun."},{"key":"2881_CR324","doi-asserted-by":"crossref","unstructured":"Weissenrieder, J. S. et al. Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity. Cell Rep. 44, (2025).","DOI":"10.1016\/j.celrep.2025.115627"},{"key":"2881_CR325","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.ccell.2021.05.005","volume":"39","author":"KP Simeonov","year":"2021","unstructured":"Simeonov, K. P. et al. Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states. Cancer cell. 39, 1150\u20131162 (2021).","journal-title":"Cancer cell."},{"key":"2881_CR326","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1158\/2159-8290.CD-23-1332","volume":"14","author":"RN Serio","year":"2024","unstructured":"Serio, R. N. et al. Clonal lineage tracing with somatic delivery of recordable barcodes reveals migration histories of metastatic prostate cancer. Cancer Discov. 14, 1990\u20132009 (2024).","journal-title":"Cancer Discov."},{"key":"2881_CR327","doi-asserted-by":"crossref","unstructured":"Nadalin, F. et al. Multi-omic lineage tracing predicts the transcriptional, epigenetic and genetic determinants of cancer evolution. 15, 7609, (2024).","DOI":"10.1038\/s41467-024-51424-4"},{"key":"2881_CR328","doi-asserted-by":"crossref","unstructured":"De Angelis, M. L. et al. An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile. J. Exp. Clin. Cancer Res. 41, 86 (2022).","DOI":"10.1186\/s13046-022-02263-y"},{"key":"2881_CR329","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41418-023-01126-z","volume":"30","author":"RRJ Low","year":"2023","unstructured":"Low, R. R. J. et al. S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer. Cell Death Differ. 30, 1155\u20131165 (2023).","journal-title":"Cell Death Differ."},{"key":"2881_CR330","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.7150\/jca.35180","volume":"10","author":"M Elmasry","year":"2019","unstructured":"Elmasry, M. et al. RBP7 is a clinically prognostic biomarker and linked to tumor invasion and EMT in colon cancer. J. Cancer 10, 4883 (2019).","journal-title":"J. Cancer"},{"key":"2881_CR331","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41419-019-1601-6","volume":"10","author":"D Kim","year":"2019","unstructured":"Kim, D. et al. AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells. Cell Death Dis. 10, 361 (2019).","journal-title":"Cell Death Dis."},{"key":"2881_CR332","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1158\/2767-9764.CRC-25-0008","volume":"5","author":"Y Sheng","year":"2025","unstructured":"Sheng, Y. et al. Impact of Subcutaneous Versus Orthotopic Implantations on Patient-Derived Xenograft Transcriptomic Profiles. Cancer Res. Commun. 5, 871\u2013880 (2025).","journal-title":"Cancer Res. Commun."},{"key":"2881_CR333","first-page":"684","volume":"4","author":"H Zhang","year":"2021","unstructured":"Zhang, H., Steed, A., Co, M. & Chen, X. Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer. Cancer Drug Resist. 4, 684\u2013709 (2021).","journal-title":"Cancer Drug Resist."},{"key":"2881_CR334","doi-asserted-by":"publisher","first-page":"1485817","DOI":"10.3389\/fimmu.2025.1485817","volume":"16","author":"LM Moser","year":"2025","unstructured":"Moser, L. M. et al. CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma. Front. Immunol. 16, 1485817 (2025).","journal-title":"Front. Immunol."},{"key":"2881_CR335","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40164-024-00576-6","volume":"13","author":"J Pu","year":"2024","unstructured":"Pu, J. et al. Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma. Exp. Hematol. Oncol. 13, 105 (2024).","journal-title":"Exp. Hematol. Oncol."},{"key":"2881_CR336","doi-asserted-by":"crossref","unstructured":"Li, Y., Sharma, A., Maciaczyk, J. & Schmidt-Wolf, I. G. H. Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside. 23, 1311 (2022).","DOI":"10.3390\/ijms23031311"},{"key":"2881_CR337","first-page":"37","volume":"6","author":"CA Hu","year":"2023","unstructured":"Hu, C. A. new\u201d single\u201d era of biomedicine and implications in disease research. J. Bio-X Res. 6, 37\u201348 (2023).","journal-title":"J. Bio-X Res."},{"key":"2881_CR338","doi-asserted-by":"publisher","first-page":"113993","DOI":"10.1016\/j.yexcr.2024.113993","volume":"437","author":"EMB Quinsgaard","year":"2024","unstructured":"Quinsgaard, E. M. B., Korsnes, M. S., Korsnes, R. & Moestue, S. A. Single-cell tracking as a tool for studying EMT-phenotypes. Exp. Cell Res. 437, 113993 (2024).","journal-title":"Exp. Cell Res."},{"key":"2881_CR339","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1158\/0008-5472.CAN-19-1427","volume":"80","author":"AR Lourenco","year":"2020","unstructured":"Lourenco, A. R. et al. Differential contributions of pre-and post-EMT tumor cells in breast cancer metastasis. Cancer Res. 80, 163\u2013169 (2020).","journal-title":"Cancer Res."},{"key":"2881_CR340","doi-asserted-by":"crossref","unstructured":"Pixberg, C. et al. Analysis of DNA methylation in single circulating tumor cells. 36, 3223\u20133231 (2017).","DOI":"10.1038\/onc.2016.480"},{"key":"2881_CR341","doi-asserted-by":"crossref","unstructured":"Roma-Rodrigues, C., Mendes, R., Baptista, P. V. & Fernandes, A. R. Targeting tumor microenvironment for cancer therapy. Int. J. Mol. Sci. 20, (2019).","DOI":"10.3390\/ijms20040840"},{"key":"2881_CR342","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/s42003-023-05667-4","volume":"6","author":"S Shen","year":"2023","unstructured":"Shen, S. et al. Tumor microenvironment remodeling plus immunotherapy could be used in mesenchymal-like tumor with high tumor residual and drug resistant rate. Commun. Biol. 6, 1281 (2023).","journal-title":"Commun. Biol."},{"key":"2881_CR343","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41392-024-01885-2","volume":"9","author":"X Shi","year":"2024","unstructured":"Shi, X. et al. Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives. Signal Transduct. Target. Ther. 9, 192 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2881_CR344","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13045-024-01634-6","volume":"18","author":"A Glaviano","year":"2025","unstructured":"Glaviano, A. et al. Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition. J. Hematol. Oncol. 18, 6 (2025).","journal-title":"J. Hematol. Oncol."},{"key":"2881_CR345","doi-asserted-by":"crossref","unstructured":"Yang, S. et al. Organoids: The current status and biomedical applications. MedComm. 4, e274 (2023).","DOI":"10.1002\/mco2.274"},{"key":"2881_CR346","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41392-022-01024-9","volume":"7","author":"X-Y Tang","year":"2022","unstructured":"Tang, X.-Y. et al. Human organoids in basic research and clinical applications. Signal Transduct. Target. Ther. 7, 168 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2881_CR347","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.1158\/0008-5472.CAN-09-0099","volume":"69","author":"J Lu","year":"2009","unstructured":"Lu, J. et al. Breast cancer metastasis: challenges and opportunities. Cancer Res. 69, 4951\u20134953 (2009).","journal-title":"Cancer Res."},{"key":"2881_CR348","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba9319","volume":"6","author":"W Wang","year":"2020","unstructured":"Wang, W. et al. Live-cell imaging and analysis reveal cell phenotypic transition dynamics inherently missing in snapshot data. Sci. Adv. 6, eaba9319 (2020).","journal-title":"Sci. Adv."},{"key":"2881_CR349","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3892\/ijo.2022.5360","volume":"60","author":"T Tan","year":"2022","unstructured":"Tan, T. et al. Epigenetic modification regulates tumor progression and metastasis through EMT. Int. J. Oncol. 60, 70 (2022).","journal-title":"Int. J. Oncol."},{"key":"2881_CR350","volume":"12","author":"M Cortesi","year":"2020","unstructured":"Cortesi, M. et al. Computational models to explore the complexity of the epithelial to mesenchymal transition in cancer. Wiley Interdiscip. Rev.: Syst. Biol. Med. 12, e1488 (2020).","journal-title":"Wiley Interdiscip. Rev.: Syst. Biol. Med."},{"key":"2881_CR351","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fbioe.2020.00220","volume":"8","author":"P Chakraborty","year":"2020","unstructured":"Chakraborty, P. et al. Comparative study of transcriptomics-based scoring metrics for the epithelial-hybrid-mesenchymal spectrum. Front. Bioeng. Biotechnol. 8, 220 (2020).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"2881_CR352","doi-asserted-by":"crossref","unstructured":"Sinha, D., Saha, P., Samanta, A. & Bishayee, A. Emerging concepts of hybrid epithelial-to-mesenchymal transition in cancer progression. Biomolecules. 10, (2020).","DOI":"10.3390\/biom10111561"},{"key":"2881_CR353","doi-asserted-by":"publisher","DOI":"10.1177\/20417314251319475","volume":"16","author":"X Fan","year":"2025","unstructured":"Fan, X. et al. Strategies to overcome the limitations of current organoid technology - engineered organoids. J. tissue Eng. 16, 20417314251319475 (2025).","journal-title":"J. tissue Eng."},{"key":"2881_CR354","doi-asserted-by":"crossref","unstructured":"Sakthivel, V., Dharshan, S. S., Namasivayam, S. K. R. & Arockiaraj, J. Advances in 3D Organoids and Organ-on-a-Chip Systems for Biomedical Research. 114, e70028, (2026).","DOI":"10.1002\/jbma.70028"},{"key":"2881_CR355","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-025-00560-7","volume":"14","author":"Y-H Teng","year":"2025","unstructured":"Teng, Y.-H. et al. TGF-\u03b2 signaling redirects Sox11 gene regulatory activity to promote partial EMT and collective invasion of oncogenically transformed intestinal organoids. Oncogenesis 14, 17 (2025).","journal-title":"Oncogenesis"},{"key":"2881_CR356","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116909","volume":"45","author":"L Lan","year":"2026","unstructured":"Lan, L. et al. A Jagged1-regulated hybrid-EMT state identifies pancreatic cancer stem cells. Cell Rep. 45, 116909 (2026).","journal-title":"Cell Rep."},{"key":"2881_CR357","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1007\/s00018-020-03449-3","volume":"77","author":"R Mohammadinejad","year":"2020","unstructured":"Mohammadinejad, R. et al. EMT signaling: potential contribution of CRISPR\/Cas gene editing. Cell. Mol. Life Sci. 77, 2701\u20132722 (2020).","journal-title":"Cell. Mol. Life Sci."},{"key":"2881_CR358","doi-asserted-by":"crossref","unstructured":"S. V. S., Augustine et al. Revitalizing oral cancer research: CRISPR-Cas9 technology the promise of genetic editing. Front. Oncol. 14, 1383062 (2024).","DOI":"10.3389\/fonc.2024.1383062"},{"key":"2881_CR359","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1038\/s41418-023-01193-2","volume":"30","author":"Z Huang","year":"2023","unstructured":"Huang, Z., Kaller, M. & Hermeking, H. CRISPR\/Cas9-mediated inactivation of miR-34a and miR-34b\/c in HCT116 colorectal cancer cells: comprehensive characterization after exposure to 5-FU reveals EMT and autophagy as key processes regulated by miR-34. Cell Death Differ. 30, 2017\u20132034 (2023).","journal-title":"Cell Death Differ."},{"key":"2881_CR360","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1158\/1538-7445.AM2019-1885","volume":"79","author":"W Shu","year":"2019","unstructured":"Shu, W. et al. CRISPR\/Cas9 engineered immortalized breast epithelial MCF10A reporter line for EMT studies and anti-cancer drug discovery. Cancer Res. 79, 1885\u20131885 (2019).","journal-title":"Cancer Res."},{"key":"2881_CR361","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05824-1","volume":"22","author":"G Zeng","year":"2024","unstructured":"Zeng, G. et al. Advancing cancer research through organoid technology. J. Transl. Med. 22, 1007 (2024).","journal-title":"J. Transl. Med."},{"key":"2881_CR362","doi-asserted-by":"publisher","first-page":"1545017","DOI":"10.3389\/fgene.2025.1545017","volume":"16","author":"V Hanitrarimalala","year":"2025","unstructured":"Hanitrarimalala, V. et al. In vitro 3D modeling of colorectal cancer: the pivotal role of the extracellular matrix, stroma and immune modulation. Front. Genet. 16, 1545017 (2025).","journal-title":"Front. Genet."},{"key":"2881_CR363","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02407-x","volume":"11","author":"J Wang","year":"2025","unstructured":"Wang, J. et al. Tumor organoid-immune co-culture models: exploring a new perspective of tumor immunity. Cell Death Discov. 11, 195 (2025).","journal-title":"Cell Death Discov."},{"key":"2881_CR364","doi-asserted-by":"crossref","unstructured":"Giron-Michel, J. et al. State-of-the-art liver cancer organoids: modeling cancer stem cell heterogeneity for personalized treatment. BioDrugs. 39, 237\u2013260 (2025).","DOI":"10.1007\/s40259-024-00702-0"},{"key":"2881_CR365","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s44164-025-00084-9","volume":"4","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Colorectal carcinoma organoid and cancer-associated fibroblasts co-culture system for drug evaluation. Vitr. models 4, 31\u201344 (2025).","journal-title":"Vitr. models"},{"key":"2881_CR366","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/ph18010062","volume":"18","author":"Q-S Feng","year":"2025","unstructured":"Feng, Q.-S. et al. Facilitation of Tumor Stroma-Targeted therapy: model difficulty and Co-Culture organoid method. Pharmaceuticals 18, 62 (2025).","journal-title":"Pharmaceuticals"},{"key":"2881_CR367","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13045-019-0829-z","volume":"13","author":"GJ Yoshida","year":"2020","unstructured":"Yoshida, G. J. Applications of patient-derived tumor xenograft models and tumor organoids. J. Hematol. Oncol. 13, 4 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"2881_CR368","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70059","volume":"6","author":"A Gu","year":"2025","unstructured":"Gu, A., Li, J., Li, M.-Y. & Liu, Y. Patient-derived xenograft model in cancer: establishment and applications. MedComm (2020) 6, e70059 (2025).","journal-title":"MedComm (2020)"},{"key":"2881_CR369","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1002\/ijc.32662","volume":"146","author":"J Shi","year":"2020","unstructured":"Shi, J., Li, Y., Jia, R. & Fan, X. The fidelity of cancer cells in PDX models: Characteristics, mechanism and clinical significance. Int. J. cancer 146, 2078\u20132088 (2020).","journal-title":"Int. J. cancer"},{"key":"2881_CR370","doi-asserted-by":"publisher","first-page":"a041329","DOI":"10.1101\/cshperspect.a041329","volume":"14","author":"MT Lewis","year":"2024","unstructured":"Lewis, M. T. & Caldas, C. The power and promise of patient-derived xenografts of human breast cancer. Cold Spring Harb. Perspect. Med. 14, a041329 (2024).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2881_CR371","doi-asserted-by":"crossref","unstructured":"Shah, S. & D\u2019Souza, G. G. M. Modeling tumor microenvironment complexity in vitro: spheroids as physiologically relevant tumor models and strategies for their analysis. 14, 732 (2025).","DOI":"10.3390\/cells14100732"},{"key":"2881_CR372","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41568-025-00803-0","volume":"25","author":"KL Simpson","year":"2025","unstructured":"Simpson, K. L., Rothwell, D. G., Blackhall, F. & Dive, C. Challenges of small cell lung cancer heterogeneity and phenotypic plasticity. Nat. Rev. Cancer 25, 447\u2013462 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"2881_CR373","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Patient-derived xenograft models in cancer therapy: technologies and applications. Signal Transduct. Target Ther. 8, 160 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"2881_CR374","doi-asserted-by":"crossref","unstructured":"De Angelis, M. L. et al. An Orthotopic Patient-Derived Xenograft (PDX) Model Allows the Analysis of Metastasis-Associated Features in Colorectal Cancer. 2022, (2022).","DOI":"10.3389\/fonc.2022.869485"},{"key":"2881_CR375","doi-asserted-by":"publisher","first-page":"1415820","DOI":"10.3389\/fonc.2024.1415820","volume":"14","author":"J Chen","year":"2025","unstructured":"Chen, J. et al. Therapies targeting triple-negative breast cancer: a perspective on anti-FGFR. Front. Oncol. 14, 1415820 (2025).","journal-title":"Front. Oncol."},{"key":"2881_CR376","unstructured":"Liu, H. et al. High cellular plasticity state of medulloblastoma local recurrence and distant dissemination. Cell Rep. Med. 6, (2025)."},{"key":"2881_CR377","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Patient-derived xenograft models in cancer therapy: technologies and applications. Signal Transduct. Target. Ther. 8, 160 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2881_CR378","doi-asserted-by":"crossref","unstructured":"Baul, S. et al. Integrating spatial transcriptomics and bulk RNA-seq: predicting gene expression with enhanced resolution through graph attention networks. Brief. Bioinform. 25, (2024).","DOI":"10.1093\/bib\/bbae316"},{"key":"2881_CR379","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/bcr2789","volume":"13","author":"CD May","year":"2011","unstructured":"May, C. D. et al. Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression. Breast Cancer Res. 13, 202 (2011).","journal-title":"Breast Cancer Res."},{"key":"2881_CR380","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06422-5","volume":"23","author":"Y Xie","year":"2025","unstructured":"Xie, Y. et al. Epithelial-mesenchymal transition orchestrates tumor microenvironment: current perceptions and challenges. J. Transl. Med 23, 386 (2025).","journal-title":"J. Transl. Med"},{"key":"2881_CR381","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3389\/fonc.2020.00499","volume":"10","author":"I Georgakopoulos-Soares","year":"2020","unstructured":"Georgakopoulos-Soares, I., Chartoumpekis, D. V., Kyriazopoulou, V. & Zaravinos, A. EMT factors and metabolic pathways in cancer. Front. Oncol. 10, 499 (2020).","journal-title":"Front. Oncol."},{"key":"2881_CR382","doi-asserted-by":"crossref","unstructured":"Lavin, D. P. & Tiwari, V. K. Unresolved complexity in the gene regulatory network underlying EMT. Front Oncol. 10, 554 (2020).","DOI":"10.3389\/fonc.2020.00554"},{"key":"2881_CR383","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.144","volume":"3","author":"Z Huang","year":"2022","unstructured":"Huang, Z. et al. Epithelial-mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities. MedComm 3, e144 (2022).","journal-title":"MedComm"},{"key":"2881_CR384","doi-asserted-by":"crossref","unstructured":"Biray Avci, C. et al. Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications. Front Pharm. 15, 1442888 (2024).","DOI":"10.3389\/fphar.2024.1442888"},{"key":"2881_CR385","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nm.2401","volume":"17","author":"M Korpal","year":"2011","unstructured":"Korpal, M. et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat. Med. 17, 1101\u20131108 (2011).","journal-title":"Nat. Med."},{"key":"2881_CR386","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.humimm.2020.12.001","volume":"82","author":"R Mathur","year":"2021","unstructured":"Mathur, R. et al. Predicting the functional consequences of genetic variants in co-stimulatory ligand B7-1 using in-silico approaches. Hum. Immunol. 82, 103\u2013120 (2021).","journal-title":"Hum. Immunol."},{"key":"2881_CR387","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154892","volume":"251","author":"A Pant","year":"2023","unstructured":"Pant, A. et al. Assessment of MMP14, CAV2, CLU and SPARCL1 expression profiles in endometriosis. Pathol. - Res. Pract. 251, 154892 (2023).","journal-title":"Pathol. - Res. Pract."},{"key":"2881_CR388","doi-asserted-by":"crossref","unstructured":"Ranga, V. et al. Role of RGD-binding Integrins in ovarian cancer progression, metastasis and response to therapy. Integr. Biol. 17, (2025).","DOI":"10.1093\/intbio\/zyaf003"},{"key":"2881_CR389","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41388-020-01566-8","volume":"40","author":"W-H Lin","year":"2021","unstructured":"Lin, W.-H. et al. STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT\u2013MET switch and cancer metastasis. Oncogene 40, 791\u2013805 (2021).","journal-title":"Oncogene"},{"key":"2881_CR390","doi-asserted-by":"publisher","DOI":"10.1016\/j.oor.2025.100767","volume":"16","author":"R Bhushan","year":"2025","unstructured":"Bhushan, R. et al. The role of artificial intelligence in predicting cancer immunotherapy response. Oral. Oncol. Rep. 16, 100767 (2025).","journal-title":"Oral. Oncol. Rep."},{"key":"2881_CR391","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-025-02218-0","volume":"18","author":"TC Dakal","year":"2025","unstructured":"Dakal, T. C. et al. Overexpression of CCK Neuropeptide in brain is linked to ZBTB20 mutations: potential diagnostic relevance in glioblastoma. BMC Med. Genomics 18, 150 (2025).","journal-title":"BMC Med. Genomics"},{"key":"2881_CR392","doi-asserted-by":"publisher","first-page":"108487","DOI":"10.1016\/j.compbiolchem.2025.108487","volume":"118","author":"GS Kakde","year":"2025","unstructured":"Kakde, G. S., Dakal, T. C. & Maurya, P. K. Understanding the IDH1 missense SNPs on expression of genes involved in Glioblastoma multiforme. Comput. Biol. Chem. 118, 108487 (2025).","journal-title":"Comput. Biol. Chem."},{"key":"2881_CR393","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.neuroscience.2025.03.047","volume":"573","author":"TC Dakal","year":"2025","unstructured":"Dakal, T. C. et al. Systematic comprehension of genomics and mutational landscape of glioma: A goal towards advanced therapeutics. Neuroscience 573, 491\u2013504 (2025).","journal-title":"Neuroscience"},{"key":"2881_CR394","doi-asserted-by":"crossref","unstructured":"Dakal, T. C., Xu, C. & Kumar, A. Advanced computational tools, artificial intelligence and machine-learning approaches in gut microbiota and biomarker identification. 6, (2025).","DOI":"10.3389\/fmedt.2024.1434799"},{"key":"2881_CR395","doi-asserted-by":"crossref","unstructured":"Dakal, T. C. & Gupta, B. in RNA-Based Cancer Therapeutics: Techniques, Applications and Challenges in Prognosis (eds Narendra Kumar Sharma, Tikam Chand Dakal, Pawan Kumar Maurya, & Gulshan Wadhwa) 1-13 (Springer Nature Singapore, (2025).","DOI":"10.1007\/978-981-96-3456-9_1"},{"key":"2881_CR396","doi-asserted-by":"crossref","unstructured":"Beura, A., Manjunath, G. K., Dakal, T. C. & Kumar, A. In Progress in Molecular Biology and Translational Science (ed. Prashanth N. Suravajhala). Academic Press. 214, 101\u2013143 (2025).","DOI":"10.1016\/bs.pmbts.2025.05.002"},{"key":"2881_CR397","doi-asserted-by":"crossref","unstructured":"Dakal, T. C., Kumar, A. & Maurya, P. K. CircRNA-miRNA-mRNA interactome analysis in endometrial cancer. J. Biomol. Struct. Dyn. 43, 1486\u20131497 (2025).","DOI":"10.1080\/07391102.2023.2291834"},{"key":"2881_CR398","doi-asserted-by":"crossref","unstructured":"Kruthi, N., Bhatankar, J., Dhakar, R. & Dakal, T. C. in RNA-Based Cancer Therapeutics: Techniques, Applications and Challenges in Prognosis (eds Narendra Kumar Sharma, Tikam Chand Dakal, Pawan Kumar Maurya, & Gulshan Wadhwa) 151\u2013174 Springer Nature Singapore, (2025).","DOI":"10.1007\/978-981-96-3456-9_7"},{"key":"2881_CR399","doi-asserted-by":"crossref","unstructured":"Sharma, A. et al. Genome organization in proximity to the BAP1 locus appears to play a pivotal role in a variety of cancers. 111, 1385\u20131391 (2020).","DOI":"10.1111\/cas.14319"},{"key":"2881_CR400","doi-asserted-by":"crossref","unstructured":"Sharma, A. et al. PPAR-Responsive Elements Enriched with Alu Repeats May Contribute to Distinctive PPAR\u03b3\u2013DNMT1 Interactions in the Genome. 13, 3993 (2021).","DOI":"10.3390\/cancers13163993"},{"key":"2881_CR401","doi-asserted-by":"crossref","unstructured":"Qin, J. et al. Systematic discrimination of the repetitive genome in proximity of ferroptosis genes and a novel prognostic signature correlating with the oncogenic lncRNA CRNDE in multiple myeloma. 12, (2022).","DOI":"10.3389\/fonc.2022.1026153"},{"key":"2881_CR402","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neo.2014.10.009","volume":"17","author":"RP Gajula","year":"2015","unstructured":"Gajula, R. P. et al. Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells. Neoplasia 17, 16\u201331 (2015).","journal-title":"Neoplasia"},{"key":"2881_CR403","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/hmg\/ddaa076","volume":"29","author":"M Khot","year":"2020","unstructured":"Khot, M. et al. Twist1 induces chromosomal instability (CIN) in colorectal cancer cells. Hum. Mol. Genet. 29, 1673\u20131688 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"2881_CR404","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03523-3","volume":"20","author":"H Sun","year":"2022","unstructured":"Sun, H. et al. Glutamine deficiency promotes recurrence and metastasis in colorectal cancer through enhancing epithelial\u2013mesenchymal transition. J. Transl. Med. 20, 330 (2022).","journal-title":"J. Transl. Med."},{"key":"2881_CR405","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/mc.23497","volume":"62","author":"G Adhikary","year":"2023","unstructured":"Adhikary, G. et al. Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation. Mol. Carcinogenes. 62, 438\u2013449 (2023).","journal-title":"Mol. Carcinogenes."},{"key":"2881_CR406","doi-asserted-by":"crossref","unstructured":"Steinbichler, T. et al. Slug is a surrogate marker of epithelial to mesenchymal transition (EMT) in head and neck cancer. 9, 2061 (2020).","DOI":"10.3390\/jcm9072061"},{"key":"2881_CR407","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.898583","volume":"12","author":"C Wei","year":"2022","unstructured":"Wei, C. et al. Cordycepin inhibits triple-negative breast cancer cell migration and invasion by regulating EMT-TFs SLUG, TWIST1, SNAIL1, and ZEB1. Front. Oncol. 12, 898583 (2022).","journal-title":"Front. Oncol."},{"key":"2881_CR408","doi-asserted-by":"publisher","first-page":"13354","DOI":"10.3390\/ijms232113354","volume":"23","author":"L Ding","year":"2022","unstructured":"Ding, L. et al. Bufalin inhibits tumorigenesis, stemness, and epithelial\u2013mesenchymal transition in colorectal cancer through a C-Kit\/Slug signaling axis. Int. J. Mol. Sci. 23, 13354 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2881_CR409","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104948","volume":"111","author":"JH Moon","year":"2020","unstructured":"Moon, J. H. et al. Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells. Oral. Oncol. 111, 104948 (2020).","journal-title":"Oral. Oncol."},{"key":"2881_CR410","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0988-0","volume":"18","author":"Y-S Weng","year":"2019","unstructured":"Weng, Y.-S. et al. MCT-1\/miR-34a\/IL-6\/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer. Mol. cancer 18, 42 (2019).","journal-title":"Mol. cancer"},{"key":"2881_CR411","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12776","volume":"53","author":"W Liu","year":"2020","unstructured":"Liu, W. et al. IL-6 promotes metastasis of non-small-cell lung cancer by up-regulating TIM-4 via NF-\u03baB. Cell Prolif. 53, e12776 (2020).","journal-title":"Cell Prolif."},{"key":"2881_CR412","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.7150\/ijbs.45446","volume":"16","author":"C Jia","year":"2020","unstructured":"Jia, C. et al. Cancer-associated Fibroblasts induce epithelial-mesenchymal transition via the Transglutaminase 2-dependent IL-6\/IL6R\/STAT3 axis in Hepatocellular Carcinoma. Int. J. Biol. Sci. 16, 2542 (2020).","journal-title":"Int. J. Biol. Sci."},{"key":"2881_CR413","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s12282-019-00966-3","volume":"26","author":"X Gao","year":"2019","unstructured":"Gao, X. et al. PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation. Breast Cancer 26, 663\u2013671 (2019).","journal-title":"Breast Cancer"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02881-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02881-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02881-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:01:49Z","timestamp":1787097709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02881-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":413,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2881"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02881-4","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"334"}}